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Abstract 
Potentially translatable short open reading frames (sORFs) of less than 100 codons are present on 
both mRNAs and non-coding RNAs (ncRNAs) and 50% of mammalian mRNAs contain at least 
one sORF. We hypothesize that a subset of sORFs encode for functional short peptides (sPEPs) that 
are expressed and contribute to proteome complexity. Our recent bioinformatic studies showed that 
nearly 2% of sORFs are conserved between several species indicating that these sORFs may have 
critical functions. Recent proteomic studies have identified over 1,000 sPEPs in human cell lines 
showing that some sORFs are indeed translated. Surprisingly, a number of peptides have been 
identified that are encoded by sORFs present in ncRNAs. In order to extend and validate these 
studies, I extracted low molecular weight proteins from HeLa and HEK293 cell lysates by either 
SDS-PAGE or ERLIC fractionation. These extracts were digested with trypsin or LysC and 
analysed by nano LC-MS/MS. The resulting MS/MS data was searched against the 
UniProKB/Swiss-Prot using MASCOT version 2.4 to filter out known proteins, and all unmatched 
spectra were searched against the human RefSeq database. ProteinPilotTM  was also used to 
identify sORF-encoded peptides by searching against an in-house sORF and the Human Alternative 
Open Reading Frame (HaltORF) databases. To date, I have identified several sPEPs including three 
that are novel. These sPEPs have a mass of less than 20 kDa. One of those is expressed from an 
ncRNA transcript and is expected to be secreted. The other two sPEPs are encoded by upstream 
open reading frames (uORFs) on mRNA transcripts; one of these is predicted to localise to the 
cytoplasm while the other is expected to be secreted. The role, if any, of these peptides has yet to be 
determined but their identification has provided a pool of candidates for further molecular 
characterization in order to determine their function. 
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Translation initiation of eukaryotic mRNAs is via the scanning mechanism, which starts with the 
migration of the pre-initiation complex along the 5'- untranslated region (5'UTR) until an 
appropriate AUG codon is reached (Wang and Rothnagel, 2004). Specific eukaryotic initiation 
factors (eIFs) including eIF2-GTP/Met- tRNA, eIF1A, and eIF3, and the initiator methionine-tRNA 
carried by the 40S ribosome subunits form a pre-initiation complex, known as the 43S complex 
(Rogozin et al., 2001). The 43S complex scans the mRNA along the 5' UTR in a 5' to 3' direction 
until an AUG start codon is encountered. At this stage, 60S subunits are involved the formation of 
an 80S ribosome that allows the decoding of RNA into protein (Rogozin et al., 2001) (Figure 1.1). 
Translation of most eukaryotic mRNAs are initiated at the first AUG triplet in the 5' UTR (Rogozin 
et al., 2001). However, in some cases, alternative initiation of translation at different start codons 
exists, especially for some growth factor genes and proto-oncogenes (Willis, 1999).The most 
efficient context for translational initiation at a AUG start codon is known as the Kozak sequence 
(GCCA/GCCAUGG), which is a consensus sequence for translational initiation of eukaryotic 
mRNAs (Crowe et al., 2006). The most critical positions within this sequence are positions -3(A or 
G) and +4 (G) which determine the strength of the initiator and translational efficiency (Crowe et al., 
2006). 
There are two mechanisms involved in the ribosomal scanning models that modify the translation of 
the main ORF down-stream with one or more uAUGs or uORFs (Wang and Rothnagel, 2004): 1) 
The leaky scanning mechanism (Figure 1.2c). 2) and the re-initiation mechanism (Figure 1.2b). The 
leaky scanning mechanism occurs when some 40S subunits do not recognize every uAUG codon, as 
a result, some ribosomes will then initiate at the downstream AUG codon (Wang and Rothnagel, 
2004). The re-initiation mechanism is thought to be inefficient since it only occurs in short uORFs 
after their translation (Wang and Rothnagel, 2004), where the 40S subunit remains bound to the 
mRNA after translation and continues to initiate at a downstream AUG codon (Meijer and Thomas, 
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2002). The relatively short time between the initiation and termination is thought to be able to 
induce re-binding between initiation factors and the 40S ribosomal subunit. As the distance between 
two ORFs increases, the time for reloading the 40S subunit will then increase, resulting in the 
enhancement of re-initiation efficiency (Meijer and Thomas, 2002). 
 
 
Figure 1.1. The mechanism of translation initiation on eukayrotic mRNAs.  
The attachment of 40S ribosomal subunit at the 5'-end of the mRNA and then migrates along the 
5'-UTR until an AUG initiator codon is encountered. A large 60S subunit binds to the 40S subunit 
and the complete ribosomal complex triggers translation for protein synthesis (Ao-Kondo et al., 
2011). 
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Figure 1.2. The irregular model of ribosomal scanning mechanisms on eukaryotic mRNAs. 
a) The regular model of ribosomal scanning mechanism on eukaryotic mRNAs. The 40S complex 
scans the mRNA along the 5' UTR in a 5' to 3' direction until an AUG start codon is encountered. 
At this stage, 60S subunits are involved the formation of an 80S ribosome that allows the decoding 
of RNA into protein (Rogozin et al., 2001). b) Re-initiation mechanism is initiated when the 40S 
subunit remains to the mRNA after translation and continues to initiate at a downstream AUG 
codon. The relatively short time between the initiation and termination is thought to be able to 
induce re-binding between initiation factors and the 40S ribosomal subunit (Meijer and Thomas, 
2002). c) Leaky scanning occurs when some 40S subunits do not recognize every uAUG codon, as 
a result, some ribosomes will then initiate at the start AUG (sAUG) codon (Wang and Rothnagel, 
2004). 
Short open reading frames (sORFs) are pervasive in eukaryote genomes but only a subset are likely 
to be translated. Recent innovations in computing, proteomics and high throughput analysis of 
translation start sites have sparked a renewed interest in open reading frames between 10 and 100 
codons in size. 
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Characterisation of sORFs by location 
On average, sORFs constitute about 5% of all annotated ORFs in the NCBI RefSeq database for a 
variety of eukaryotes including mammals (Kastenmayer et al., 2006). Short ORFs can occur by 
chance throughout the genome yet one study found that most sORFs (94%) are present in regions 
that are transcribed (Frith et al., 2006), indicating a high potential for expression of their encoded 
peptides. The common identifying characteristic of sORFs is the length of their open reading frames. 
Theoretically, these could be as small as 3 codons but the smallest translated sORF described to 
date is 6 codons (Law et al., 2001). The upper limit of sORFs has been arbitrarily set at 100 codons 
largely as a consequence of gene prediction algorithms ignoring open reading frames smaller than 
this (Basrai et al., 1997, Claverie, 1997). Clearly there are likely to be sORFs that extend past this 
artificial limit and indeed a recent proteomic study has identified peptides encoded by sORFs of up 
to 250 codons in length (Slavoff et al., 2013). There are five subcategories of sORFs (Figure 1.3): 
sORFs that are located on a variety of non-coding RNAs (ncRNAs: long, intergenic and anti-sense); 
upstream open reading frames (uORFs) located within the 5′ UTR of mRNAs; downstream open 
reading frames (dORFs) located within the 3′ UTR; short overlapping ORFs (oORFs) that are in the 
mCDS or located out of the mCDS in non-canonical +2 and +3 open reading frames. 
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Figure 1.3. Schematic showing the various geographic locations of sORFs. 
There are five subcategories of sORFs (shown in boxes): sORFs that are located on a variety of 
non-coding RNAs (ncRNAs: long, intergenic and anti-sense); upstream open reading frames 
(uORFs) located within the 5′ UTR (5′ leader) of mRNAs; downstream open reading frames 
(dORFs) located within the 3′ UTR (3′ trailer); short overlapping ORFs (oORFs) that are in the 
mCDS or t located out of the mCDS in non-canonical +2 and +3 open reading frames. 
Small coding sequence in 5'UTRs (uORFs) 
uORFs refer to one or more ORFs located in the 5'UTR prior to the main open reading frame 
(mORF). These uORFs are regarded as important elements involved in transcriptional regulation in 
the cis-regulation of gene expression (Wethmar et al., 2010). The influence of individual uORFs on 
translation of the downstream mORF is determined by characteristics such as length, number per 
transcript, secondary context and distance to the mORF (Wethmar et al., 2010). 
The occurrence of at least one uAUG contained in vertebrate mRNAs has been shown to range from 
11% to 42% depending on the species (Kozak, 1987, Pesole et al., 2000). For human specifically, 
20%-49% of mRNAs have been found to contain at least one uAUG (Pesole et al., 2000, Davuluri 
et al., 2000, Barbosa et al., 2013). Several studies showed that the presence of uAUGs/uORFs 
would reduce the number of ribosomes that initiates the AUG start codons and subsequently 
diminishes the efficiency of translational initiation on the mORF (Meijer and Thomas, 2002, 
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Davuluri et al., 2000). The conservation of uORFs has been reported in several species such as 
human, mice, yeast, plants and insects (Table A1). 
Small coding sequence in non-coding RNAs (ncRNAs) 
sORFs also appear at high frequency within ncRNAs (Slavoff et al., 2013). It is believed that short 
ncRNAs (~50 nt) are too small to be translated so most translatable sORFs are generally thought to 
be found on long ncRNAs (IncRNAs) (~200 nt) (Kageyama et al., 2011). However, ribosomal 
profiling has been reported to detect translation initiation sites (TIS) on short ncRNAs (Lee et al., 
2012). Around 600,000 potential ncRNAs had been identified in Arabidopsis with the analysis of 
intergenic (Hanada et al., 2007) and whole genome sequences (Lease and Walker, 2006). 
Identification of ncRNAs in different species, such as Drosophila (Ladoukakis et al., 2011), plant 
(Yang et al., 2011), mice (Frith et al., 2006) and human (Slavoff et al., 2013) have also been 
reported. 
Small coding sequence in mRNAs: oORFs, dORFs 
oORFs has been differentiated into a number of subtypes: those that sit within a mORF; those that 
extend from the mORF to 3'UTR and dual-coding transcripts produced by alternative splicing 
(Ribrioux et al., 2008, Michel et al., 2012). The conservation of oORFs between human and mice 
have been reported in several studies (Chung et al., 2007, Ribrioux et al., 2008, Xu et al., 2010). 
Unlike the 5′UTR and coding regions, the 3′UTR was considered not to be translated so less 
emphasis was made to identify and characterise downstream ORFs (dORFs) (Ingolia et al., 2011). 
Nevertheless, 3′UTRs are much longer than 5′UTRs so potentially could contain more ORFs 
(Mercer et al., 2011). Although less attention has been paid to dORFs because of a lack of apparent 
functionality, there is accumulating evidence that some may be translated (Ingolia et al., 2011). 
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As out-of frame alternative translation initiation have been found to encode proteins of different 
amino acid composition in viruses and bacteriophages (Normark et al., 1983), recently studies 
reported the discovery of several protein products encoded from oORFs that are located in UTRs or 
overlapping mCDSs in non-canonical +2 and +3 open reading frames (Vanderperre et al., 2013). A 
recent study detected 1,259 alternative proteins, indicating that oORFs are indeed translated and 
contribute to human proteome (Vanderperre et al., 2013). 
Evidence of sORF translation from proteomic studies 
Peptides encoded by uORFs: uPEPs 
Proteomic studies on human cell isolates have reported that some uORFs are indeed translated to 
uPEPs (Oyama et al., 2004, Slavoff et al., 2013,Oyama et al., 2007). The first evidence for uPEPs 
using high-resolution nanoflow liquid chromatography equipped with electrospray ionization 
tandem mass spectrometry in human cells was published (Oyama et al., 2007)and they identified 
eight uPEPs in those studies. A similar proteomic approach was also performed using a 
combination of a more sensitive chromatographic method, electrostatic repulsion-hydrophilic 
interaction chromatography (ERLIC), to fractionate the peptide mixture together with RNA-seq 
transcriptome data (Slavoff et al., 2013). This resulted in the identification 90 proteins translated 
from sORFs, 22 of which were derived from the translation of uORFs (Slavoff et al., 2013). 
Peptides encoded by sORFs present in ncRNAs 
A proteomic study identified 5426 short peptides on Arabidopsis, 905 of which encoded by genes 
had not been previously annotated in the reference databases (Castellana et al., 2008). Slavoff et al. 
identified 49 sPEPs encoded from ncRNAs and 8 sPEPs from intergenic ncRNAs (lincRNAs) in 
human cell lines. 
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Peptides encoded by oORFs and dORFs: oPEPs and dPEPs 
A recent paper has identified 11 oPEPs (Slavoff et al., 2013) in human cell lines. Another proteomic 
study detected 1,259 alternative proteins in human cell lines, tissues, and fluids, indicating that 
oORFs are indeed translated and contribute to human proteome (Vanderperre et al., 2013). 
A few studies focusing on the identification of dPEPs have been published. A study reported that 
dORFs could be translated via leaky scanning and ribosomal reinitiation mechanisms or translated 
as a ribosomal entry site contained on the 3′UTR (Mercer et al., 2011). Three dPEPs translated from 
two dORFs were reported in a proteomic study (Oyama et al., 2007) and six more dPEPs were 
found in a recent proteomic paper (Slavoff et al., 2013). 
Bioinformatic identification of sPEPs 
In order to find functional sPEPs, searches for conservation between species at the amino acid level 
play an important role because cross-species conservation could indicate that the sequence is 
maintained evolutionally from a functional role. sORFs that lack cross-species conservation are 
unlikely to encode functional peptides (Andrews and Rothnagel, 2014). However, these sORFs can 
not be disregarded because they may be biologically relent to species-specific sPEPs. Bioinformatic 
studies have reported a large amount of sORFs with functional potential and which may need 
further investigation for confirmation (Table A2). Once sORFs is verified with its capability, it 
implies that the undiscovered sPEPs existing in the sORFs contribute to proteome complexity. In 
addition, a number of sPEPs have been identified from sORFs in ncRNAs and in lincRNAs (Slavoff 
et al., 2013), providing reliable evidence that human proteome is much more complicated than 
previously appreciated. 
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Ribosome profiling and identification of occupied start codons 
Ribosome profiling strategies have recently emerged as a powerful tool to map which mRNA 
transcripts are translated at any particular stage and at what efficiency based on deep sequencing of 
ribosomal protected mRNA transcripts (Kuersten et al., 2013). Ribosomal profiling has been 
reported to detect translation initiation sites (TIS) on short ncRNAs (Lee et al., 2012). Support for 
sORF translation is provided by ribosomal profiling studies, which generate a transcriptome-wide 
map of translation initiation sites. A recent study on human cells identified 4400 translation 
initiation sites that matched uORFs (Vanderperre et al., 2012) many of which show conservation in 
other species. Ribosomal footprinting technique has been developed based upon high-throughput 
DNA sequencing that provides systematic monitoring of protein translation in mammalian cells 
(Ingolia et al., 2011). To validate human TISs from the previous published uORFs, 14 of the start 
sites identified by ribosomal footprinting had been classified as demarcating functional uORFs 
(Fritsch et al., 2012) 
Identification of functional sPEPs 
uPEPs 
Despite that several uORFs are known to be translated, only a few have been identified to have 
functional roles (Table A3). For example, in Arabidopsis thaliana, expression of the CDS is 
regulated by polyamines binding to the nascent upstream sPEP; orthologous to human SAMDC1 
plasmid (Hanfrey et al., 2005). In human, a sPEP has been found to be implicated in the regulation 
of human hairles homolog (HR); 13 causative mutations of Marie Unna hereditary hypotrichosis 
have been identified within the second uORF (Wen et al., 2009). A subset of these attenuate 
translation of the downstream ORF in response to environmental signals, termed “peptoswitch” 
(Jorgensen and Dorantes-Acosta, 2012). The regulatory role of the peptoswitch is to activate uPEPs 
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to bind to small molecules through an intermediary (Jorgensen and Dorantes-Acosta, 2012). A 
recent research group reported that the expression of human microsomal epoxide hydrolase 
(EPHX1), a critical xenobiotic-metabolizing enzyme, catalyzing both detoxification and 
bioactivation reactions, was inhibited by trans-acting sPEPs that were encoded by two uORFs 
through interactions with the translation machinery (Nguyen et al., 2013). The majority of uPEPs 
function in cis-regulational translation of downstream ORF through identified mechanisms (Wen et 
al., 2009, Hanfrey et al., 2005).  
Peptides encoded from ncRNAs 
Several sPEPs on intergenic regions and ncRNAs, particularly in plants and insects, have been 
identified to be functional (Table A3). Those sPEPs have been shown to have various regulatory 
roles, although the functional mechanisms underlying their roles are still under investigation. Two 
examples of functional mechanisms underlying the sPEPs encoded from intergenic and ncRNAs 
have been reported in D. melanogaster (Magny et al., 2013, Kondo et al., 2010). Peptides of 11-32 
amino acids encoded by the polished rice (pri) on a long ncRNA has been found to control 
epidermal differentiation in D. melanogaster by triggering the amino-terminal truncation of the 
Shavenbaby (Svb) protein, thereby converting Svb from a repressor to an activator (Kondo et al., 
2010). Pri, therefore, plays an important role in providing a strict control in epidermal 
morphogenesis (Kondo et al., 2010). As a result of this study, Pri sORF have been reannotated as a 
mRNA. Another research group described two peptides of less than 30 amino acids encoded by the 
sarcolamban locus of Drosophila. These peptides regulate the calcium transport by associating with 
sarco-endoplasmic reticulum Ca2+ adenosine triphosphatase (SERCA), and hence affecting in 
regular muscle contraction in Drosophila heart (Magny et al., 2013).  
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oPEPs/ dPEPs 
Apart from uPEPs and ncRNAs, a number of oPEPs have been reported to be functional, 
particularly in plants and insects (Frank and Smith, 2002, Röhrig et al., 2002, Narita et al., 2004, 
Colombani et al., 2012). Only a few human sPEPs encoded from overlapping ORFs have been 
characterised so far (Table A3). An oPEP expressed from the intestinal carboxyl esterase gene has 
been reported to be recognized by human leukocyte antigen-B7-restricted renal cell 
carcinoma-reactive T cell clone by binding HLA-B*0702-presenting molecules (Ronsin et al., 
1999). This peptide product may be associated with regulation of gene expression and cancer by 
binding to Ag-presenting molecules and involving in Ag-processing mechanism (Ronsin et al., 
1999). Understanding the mechanisms of the translation of oORFs in tumor cells is important in the 
investigation of tumor immunology. Recent studies have characterised two oPEPs encoded from 
alternative proteins in human cell lines, AltPrP (Vanderperre et al., 2011) and AltATXN1 (Bergeron 
et al., 2013). Although only a few dPEPs have been identified, they are found to be translated from 
dORFs via leaky scanning and ribosomal reinitiation mechanisms or translated as a ribosomal entry 
site contained on the 3′UTR (Mercer et al., 2011). A recent proteomic study reported a dPEP 
encoded from a sORF within the 3ʹ trailer sequence of the murine retrovirus integration site 1 
homologue (MRVI1) gene (Vanderperre et al., 2013). The AltMRVI1 sPEP was found to colocalise 
with the breast cancer type 1 susceptibility protein (BRCA1) in the nucleus, and the interaction 
between them was also confirmed through co-immunoprecipitation (Vanderperre et al., 2013). 
However, the role of AltMRVI1 associated in this interaction remains unkown. 
Aims and Significance 
Physical evidence for sORF-encoded peptides has come from proteomic studies on human cell 
isolates using 2D nano-liquid chromatography-tandem mass spectrometry (Oyama et al., 2004, 
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Oyama et al., 2007, Vanderperre et al., 2013, Slavoff et al., 2013). We hypothesized that sORFs 
encode functional peptides and are endogenously expressed as part of the eukaryotic cellular 
proteome, contributing to proteome complexity. We believe sPEPs have biological roles beyond 
their canonical function, such as having trans-acting roles in other gene regulation pathways or 
being involved in cell development and function. 
Our recent bioinformatic studies showed that nearly 2% of sORFs are conserved between several 
species indicating that these sORFs may have critical functions. Recent proteomic studies have 
identified over 1,000 sPEPs in human cell lines showing that some sORFs are indeed translated. 
Surprisingly, a number of peptides have been identified that are encoded by sORFs present in 
ncRNAs. In order to extend and validate these studies, we extracted low molecular weight proteins 
from HeLa and HEK293 cell lysates to confirm our hypothesis that sPEPs do exist and have distinct 
biological roles in cells. 
In this project, the experimental methodology was divided into three parts, which were illustrated in 
the flowchart in Figure 1.4. 
Aim1 
The first step of this project was to validate peptide enrichment methods to reduce sample 
complexity. Low molecular weight proteins from HeLa and HEK293 cell lysates were extracted by 
either SDS-PAGE or ERLIC fractionation. These extracts were digested with trypsin or LysC and 
analysed by nano LC-MS/MS. 
Aim2 
The second step was to research the resulting MS/MS data against the UniProKB/Swiss-Prot using 
MASCOT version 2.4 to filter out known proteins, and all unmatched spectra were searched against 
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the human RefSeq database. ProteinPilotTMwas also used to identify sORF-encoded peptides by 
searching against an in-house sORF and the HaltORF databases. 
Aim3 
Bioinformatic analyses for confirmed sPEPs from the proteomic approach were performed before 
characterisation. Searches for cross-species conservation of sORFs can reveal those that encode 
potential functionally important peptides. High levels of sequence identity between sORF 
homologues are an indication that the encoded uPEP has been maintained during evolution. 
 
Figure 1.4. The overall experimental methodology for this research project. 
The flowchart consists of three main parts. Part I involves protein enrichment strategies used to 
separate polypeptides. Part II includes the development of targeted MS analysis. Part III focuses on 
bioinformatic analyses for identified sPEPs. 
Part I  
Peptide 
enrichment 
strategy 
•  Cell culture lysis and processing of 
polypeptides 
•  Validate peptide enrichment methods to 
obtain small proteins 
•  Molecular Weight Cut-Off (MWCO) + 
ERLIC (or SCX) + LC-MS/MS 
approach 
•  Gel + LC-MS/MS approach 
Part II 
LC-MS/MS 
analysis; 
Data search 
•  Analyse fractions from ERLIC, SCX, and gel 
extraction 
•  MASCOT search engine: SwissProt-> 
Unmatched MS/MS spectra against 
Human_RefSeq 
•  ProteinPilot Software: RefSeq Human RNA; 
HaltORF database; inhouse sORF list 
•  sPEPs identification  
Part III 
Bionformatic 
analyses 
•  Bioinformatic analyses for the 
confirmed sPEPs  
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Materials 
HEK293 cells / HeLa cells 
DMEM supplemented with L-glutamine, 10% v/v newborn calf serum (NCS) 
Penicillin 
Streptomycin 
Trypsin/EDTA solution 
Phosphate buffered saline (PBS) 
Bortezomib (PS-341) proteasome inhibitor (PI) 
Dimethyl sulfoxide (DMSO) 
0.25% Acetic acid 
10 kDa, 30 kDa, and 50 kDa molecular weight cut-off (MWCO) filters (Amicon Ultra Kit) 
2D Quant Kit 
Dithiothreitol (DTT) 
Iodoacetamide (IAA) 
Trypsin/ LysC digestion solution 
Acetonitrile (ACN) 
Electrostatic repulsion hydrophilic interaction chromatography (ERLIC) 
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Strong cationic exchange (SCX) 
SDS-PAGE gel electrophoresis 
LC-MS/MS 
MASCOT version 2.4/ UniProKB/Swiss-Prot search, Matrix Science Limited 
ProteinPilotTM (ABSCIEX) 
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Cell culture and lysate 
HEK293 and HeLa cells were cultured in high-glucose DMEM supplemented with L-glutamine, 
10% v/v newborn calf serum (NCS), 100 µg/ml penicillin and streptomycin. Cells were grown at 
37°C in a 5% CO2 humidified incubator. Cells were grown to give 80%-90% confluence, harvested 
with Trypsin/EDTA, and washed with phosphate buffered saline (PBS). 
Proteasome inhibitor treatment 
In order to prevent protein degradation during cell lysis, the potent 20S proteasome inhibitor (PI) 
Bortezomib (PS-341) was used to treat the cells before carrying out cell lysis. PI Bortezomib was 
firstly dissolved in 1 ml Dimethyl sulfoxide (DMSO) to give a concentration of 13 mM and then 
diluted with DMEM/Glt/NCS to 50 µM before adding to cells. Aliquots of 1X108 HEK293 cells 
grown in suspension were treated with proteasome inhibitor solution (50 µM) for 4 hours and 
washed three times with PBS. For HeLa cells, 50 µM PI treatment for 8 hours were performed 
before cell lysis. 
Boiling water (500 µl) was applied directly into the frozen cell pellets and kept boiling for 15 
minutes to destroy proteolytic activity. The sample was cooled to room temperature, sonicated on 
ice for 3 x 10 seconds at output level 4 with a 40% duty cycle (Branson Sonifier 250). Acetic acid 
was added to a final volume of 0.25% and centrifuged at 20,000xg for 20 minutes at 4°C to pellet 
insoluble material. 
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Polypeptide isolation 
Molecular Weight Cut-Off (MWCO) + ERLIC (or SCX) approach 
Reduction and alkylation 
In order to collect low molecular weight proteins and peptides, 10 kDa, 30 kDa, and 50 kDa 
molecular weight cut-off (MWCO) filters (Amicon Ultra Kit) were used. An aliquot from the 
flow-through was quantified using a2D Quant Kit (Appendix 3) (Weist et al., 2008) to determine 
protein concentration. The top concentrated fraction from the MWCO filter was also collected and 
an aliquot quantified. Samples were brought to 5 mM dithiothreitol (DTT) and then incubated at 
56°C for 30 minutes to reduce disulfide bonds. The sample reaction was cooled to room 
temperature before adding 55 mM iodoacetamide (IAA) solution to alkylate the free cys residues. 
The reaction was then incubated in the dark for 30 minutes followed by addition of more DTT (10 
mM final concentration) to quench excess IAA. 
Trypsin/ LysC digestion 
Trypsin is a protease that is often used to cleave proteins to create a basic residue at the carboxyl 
terminus of the peptide for MS/MS analysis. Trypsin was mixed with 50 mM ammonium 
bicarbonate (ABC) to give 0.2 ng/µl before applying to samples. Trypsin was added at a ratio of 
1:50 enzyme to protein (The ratio of 1:100 was attempted previously, but it was too low for peptide 
digestion). The reaction was incubated at 37°C for 16 hours. The digested sample then desalted 
using a C18 Toptip by washing with 3x150 µl 1% acetonitrile (ACN) and eluted with 2x150 µl 80% 
ACN/0.1% formic acid. The peptide mix was then dried in a SpeedVac at 45°C. 
LysC has high specificity for lysine residues and creates larger peptides than trypsin. LysC was 
used as an alternative to digest proteins since some peptide sequences might contain too many 
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arginine residues, and those peptides would be cut into too small pieces (less than 6 amino acid 
residues) by trypsin. Procedures and the concentration of LysC used were the same as that 
performed with Trypsin digestion. 
Polypeptide fraction by ERLIC 
A PolyWax column (200 mm x 4.6 mm, 5 µm, 300 Å) was used when performing ERLIC using an 
Agilent Technologies 1100 Series HPLC combined with a degasser and automatic fraction collector. 
Flow rate was set at 0.8 ml/min with a wavelength of 254 nm. An aliquot of 1 mg of protein from 
the protein sample was loaded for fractionation (150 µl/load). Twenty-five fractions were collected 
over a 77-minute linear gradient beginning with a buffer solution containing 1% acetic acid in 90% 
acetonitrile (ACN) and ending with a buffer of 0.1% formic acid in 30% acetonitrile (ACN). Protein 
samples fractionated by ERLIC were not fractionated by SCX. Fractions were then evaporated on a 
SpeedVac before re-suspending in 15 µl 0.1% formic acid and then loaded onto a C18 column for 
LC-MS/MS analysis. 
Polypeptide fraction by SCX 
Samples were first desalted using a ZipTip prior to separation on an Agilent SCX column (50 mm x 
4.6 mm, 5 µm, 300 Å) at a flow rate of 0.3ml/min beginning with buffer A containing 2% ACN/ 
0.5% acetic acid followed by buffer B containing 2% ACN/0.5% acetic acid/ 250mM ammonium 
acetate, and running for 37 minutes on an Agilent 1100 chromatography system. An aliquot of less 
than 500 µg of protein from the protein sample was loaded for fractionation (150 µl/load). 
Fractions (250 µl) were collected in a microtitre plate and then pooled to give 9 fractions in total. 
These fractions were then evaporated on a SpeedVac followed by ZipTip cleaned up before 
re-suspending in 15 µl 0.1% formic acid for LC/MS/MS analysis. 
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SDS-PAGE gel LC-MS/MS approach 
Tris-Tricine/Urea gels (SDS-PAGE) 
Tris-Tricine/Urea gels (Separation gel: 16%, 6 M urea; stacker gel: 4%) were used for protein 
separation. Loading buffer was made with 150 mM Tris-HCl pH 7.0, 12% w/v SDS, 30% v/v 
glycerol, 6% v/v mercaptoethanol, 0.05% w/v Bromophenol Blue. Volume of loading buffer needs 
to be sufficient to keep ratio of SDS:neutral at least 10:1. Then, the loading buffer was mixed with 
protein samples prior to electrophoresis. A discontinuous buffer system consisted of anode buffer (1 
M Tris-HCl, pH 8.9) and cathode buffer (1 M Tris-HCl, 1% SDS, pH 8.3) was used for 
electrophoresis. During electrophoresis, gels were initially run at 30 V and then switch to 200 V as 
samples reach the 4% stacker gel. Gels were then stained with Coomassie Blue G250 and imaged 
with Odyssey (LI-COR) (Preset: ProteinGel, Resolution: 169 µm, Channel: 700) prior to gel 
excision. 
Reduction and alkylation 
For visualization of gels, the protein sample from each lane corresponded to <20 kDa of the 
molecular weight (MW) marker were excised into several fractions between sizes15-20 kDa, 10-15 
kDa, 3.5-10 kDa, and those less than 3.5 kDa. Gel slices of each respective fraction were diced into 
1-2 mm pieces using a scalpel blade and were collected into 1.5 ml Eppendorf tubes for in-gel 
digestion prior to de-staining procedure. Gel pieces were then washed with ~500 µl of de-staining 
buffer (50% ACN, 50mM ABC). DTT (10 mM) was added to the gel pieces with 30 min-incubation 
at 56°C to reduce disulfide bonds. Samples were cooled to room temperature before adding a 55 
mM iodoacetamide (IAA) solution. Samples were incubated in the dark at room temperature for 30 
minutes. Dehydration of gel pieces was performed with 100% ACN followed by rehydration with 
Trypsin in 50 mM ABC. The digested sample then desalted using ZipTip on an Agilent C18 trap by 
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washing with 3x150 µl 1% ACN and eluted with 2x150 µl 80% ACN/0.1% formic acid. The 
peptide mix was then dried in a SpeedVac at 45°C. 
Peptide extraction 
To extract peptides from the gel pieces, extraction buffer (50% ACN/ 0.1% TFA) was added to 
samples with sonication for 10 minutes. Samples were then evaporated in a SpeedVac at 45°C. 
Before LC-MS/MS analysis, samples were desalted using ZipTip by washing with 3x10 ul 1% 
ACN and eluted with 10 ul 80% ACN/0.1% TFA. 
Nano flow LC-MS/MS analysis 
An electrospray quadrapole- time-of-flight mass spectrometer (ESI-Q-TOF MS) (Applied 
Biosystems TripleTOF 5600 System) fitted with Nanospray III source was used with across m/z 
350 – 1800. The top 20 multiply charged (2+ to 5+) peptides that had more than 100 counts 
intensity were picked for fragmentation by collision-induced dissociation (CID) across m/z 40 - 
1800 for 0.05 sec, followed by exclusion for 30 sec after 2 occurrences, with up to 20 MS/MS 
experiments per cycle (0.05 sec / spectrum). 
Database search for protein analysis 
Raw MS data files were first converted to MASCOT Generic Format using the mgf processing 
script (version 1.3) accessed via Peakview version 1.2 (ABSciex). UniProKB/Swiss-Prot database 
was used for analysis of the mass spectra of protein samples using MASCOT search engine from 
Matrix Science, accessed via the Australian Proteomics Computational Facility. The parameters for 
MASCOT MS/MS search are listed in Table A4. 
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Database search for sPEP identification 
Identification of sPEPs from the protein mix was performed using MASCOT search engine. Details 
of the process are described in Figure 2.1. According to determine how good the data searched 
against to the RefSeq database. Any peptide spectrum matches (PSMs) with a score less than 40 
were discarded since the likelihood that of a false positive increases as the score decreases. The 
remaining MS/MS data matched in human RNA database were examined to confirm that they met 
the criteria for a sPEP. Those MS/MS spectra that match main ORFs in SwissProt were excluded 
and everything else was re-searched in the RefSeq database. A good match must have high score 
obtained by MASCOT algorithm with low error values, and well-matched MS/MS spectrum in b- 
and/or y-ion coverage. In addition, the predicted peptide sequence should not sit in the mCDS of a 
gene, determined by conducting tBLASTn (NCBI) searches. In addition to MASCOT searches, the 
MS/MS data was also searched against our inhouse sORF list, and as well as to the Human 
alternative open reading frame (HaltORF) database (Vanderperre et al., 2012), using 
ProteinPilotTM (ABSCIEX), which is able to utilize a different search algorithm and it enables 
simultaneous searches that contained multiple peptide modifications, which is a limitation in the 
MASCOT MS/MS ion search algorithm. 
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Figure 2.1. Flowchart indicating the process used to identify sPEPs from MS/MS data using 
the MASCOT and ProteinPilotTM searches. 
 
Re-search data with RefSeq & 
HaltORF in ProteinPilot program 
Inhouse custom database (sORF 
list) in ProteinPilot program
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Introduction 
In order to reduce sample complexity in peptide enrichments,, low molecular weight proteins from 
HeLa and HEK293 cell lysates were extracted by either SDS-PAGE or ERLIC fractionation. These 
extracts were digested with trypsin or LysC and analysed by nano LC-MS/MS. The process to 
identifying sPEPs from the protein mix was performed using MASCOT search engine. In addition 
to MASCOT searches, the MS/MS data was also searched against our inhouse sORF list, and as 
well as to the Human alternative open reading frame (HaltORF) database (Vanderperre et al., 2012), 
using ProteinPilot!" (ABSCIEX), which is able to utilize a different search algorithm and it 
enables simultaneous searches that contained multiple peptide modifications, which is a limitation 
in the MASCOT MS/MS ion search algorithm. 
The proteomic approaches used in my project were analysed by comparing the resulting data from 
each critical procedure. In order to prevent protein degradation during cell lysis, the potent 20S 
proteasome inhibitor (PI) Bortezomib (PS-341) was used to treat the cells before carrying out cell 
lysis. Different cell batches with/without PI treatment were recorded and analysed by measuring the 
amount of protein using the 2D quant kit. The amount of protein products obtained from ERLIC 
and SCX in different rounds of attempts were analysed and compared from MASCOT searches. In 
addition, the efficiency of these peptide enrichment strategies was also analysed by comparing the 
identification of protein products after LC-MS/MS analysis.	  
Proteasome inhibitor treatment of cells 
Previous work in the laboratory had shown that half life of exogenous sPEPs was increased by the 
addition of a proteasome inhibitor (Andrews 2012). In order to prevent protein degradation, the 
potent 20S proteasome inhibitor (PI) Bortezomib (PS-341) was used to treat the cells before cell 
lysis. A test round of HeLa and HEK293 cells treated with PI in different incubation times (1 hour, 
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4 hours, 8 hours) was performed (Figure 3.1&3.2) to estimate the incubation time of PI treatment. 
HeLa cells treated with 50 µM for 8 hr. HeLa cells were still healthy after 8-hour 50 µM PI 
treatment. Therefore, HeLa cells treated with 8-hour 50 µM PI treatment were used for subsequent 
experiments. For HEK293 cells, cells were still healthy after 4-hour 50 µM PI treatment but cells 
began to detach and float on the flask after 8-hour 50 µM PI treatment. Therefore, 4-hour 50 µM PI 
treatment was demonstrated in HEK293 cells. 
 
            
Figure 3.1. Results of PI treatment in HeLa cells with different incubation times. 
A) Confluence of HeLa cells before PI treatment: ~70%. 10 x 10 magnification. B) HeLa cells 
treated with 50 µM for 1 hr.10 x 10 magnification. C) HeLa cells treated with 50 µM for 4 hr. 10 x 
10 magnification. D) HeLa cells treated with 50 µM for 8 hr. HeLa cells were still healthy after 
8-hour 50 µM PI treatment.10 x 10 magnification. Therefore, HeLa cells treated with 8-hour 50 µM 
PI treatment were used for subsequent experiments. 
A	   B  
C D 
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Figure 3.2. Results of PI treatment in HEK293 cells with different incubation times. 
A) Confluence of HEK293 cells before PI treatment: ~70%.10 x 10 magnification. B) HEK293 
cells treated with 50 µM for 4 hr. 10 x 10 magnification. C) HEK293 cells treated with 50 µM for 8 
hr. HEK293 cells were detached and floating on the flask after 8-hour 50 µM PI treatment. 10 x 10 
magnification. Therefore, HEK293 cells treated with 4-hour 50 µM PI treatment were used for 
subsequent experiments. 
Different cell batches with/without PI treatment were analysed by measuring the amount of protein 
using 2D quant kit (Figure 3.3). For HeLa cells, ~80% more protein was obtained from the cells 
with 50 µM PI treatment compared to those without PI treatment (Figure 3.4). The comparison of 
HEK293 cells with/without PI treatment indicated that the amount of protein yield was doubled 
A B
C 
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from cells with 50 µM PI treatment according to the results from 2D quant measurement (Figure 
3.5). However, in MASCOT searches, no significant increase was detected in the numbers of 
peptide yield from cells with PI treatment (Figure 3.6). 
 
Figure 3.3. Amounts of protein yields from different batches of HEK293 cell lysates 
with/without proteasome inhibitor treatment 
Different HEK293 cell batches with/without PI treatment were analysed by measuring the amount 
of protein yield using 2D quant kit. The first four lanes in the figure show protein yield from cells 
without PI treatment while the following four lanes indicates protein yield from cells treated with PI. 
The number at the top of each bar indicate actual yield in µg. Each bar represents a separate 
experiment. 
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Figure 3.4. Amount of protein products yield from HEK293 cell lysates 
A comparison of HEK293 cells with/without PI treatment indicated that the amount of protein yield 
was doubled from the cells treated with 50 µM PI. The average value is based on 8 distinct 
experiments with individual HEK293 cell batch. Standard error of the mean was displayed in the 
error bar. 
 
Figure 3.5. Amount of protein products yield from HeLa cell lysates 
Results indicate ~80% more proteins yielded from the cells with 50 µM PI treatment than those 
without PI treatment from HeLa cell lysates. The average value is based on 4 distinct experiments 
with individual HeLa cell batch.  Standard error of the mean was displayed in the error bar. 
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Figure 3.6. Numbers of peptide detected in cells with/without PI from MASCOT search 
According to MASCOT search results, the numbers of peptide did not have detectable increase in 
the cells treated with PI. 
Analysis of peptide enrichment strategies 
Molecular Weight Cut-Off (MWCO) + ERLIC (or SCX) approach 
Both ERLIC and SCX have been shown to increase detection sensitivity in peptide separation 
compared to hydrophilic interaction liquid chromatography (HILIC) (Zarei et al., 2011). Although 
the ERLIC approach in enriching peptides for MS-based identification has been reported to provide 
more advantages than the SCX approach (Gan et al., 2008), SCX has been reported to have higher 
identification of phosphopeptides (Zarei et al., 2011). In addition, ERLIC is shown to have better 
result in the separation of multi-phosphorylated peptides, while SCX is suited for the fractionation 
of mono-phosphorylated peptides (Zarei et al., 2012). Therefore, both approaches were performed 
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in my project to improve the separation and potential discovery of new sPEPs. The fractionated 
protein products obtained from ERLIC and SCX from a number of separate experiments was 
analysed by LC-MS/MS followed by MASCOT searching (Figure 3.7). From the results of protein 
identification of sPEPs from ERLIC and SCX, the last ERLIC experiment had approximate twice as 
many protein identifications as the first ERLIC experiment (Figure 3.7). As a batch of HEK293 
cells treated with PI was used for lysis, followed by a 30 kDa molecular weight cut-off (MWCO) 
filter for collection of small proteins in the last ERLIC experiment, while a batch of HEK293 cells 
was used without PI treatment, followed by a 10 kDa MWCO filter. Similar results were detected in 
the SCX experiments. The total number of proteins identified in each experiment varied quite a lot 
and may be due to differences in each protocol, including cell culturing (PI treatment) and peptide 
separation and extraction strategies. From the results, the number of protein products obtained via 
ERLIC fractionation is more than that via SCX when 1 mg of protein was used as the starting 
material for both approaches. The average value is based on 10 distinct experiments. The total 
number of sPEP identifications from ERLIC and SCX was calculated for comparison (Figure 3.8). 
Protein product identification from HEK293 cell lysates fractionated via ERLIC was ~50% higher 
than that via SCX. However, the difference in the protein product identification between ERLIC 
and SCX may be due to the different numbers of fractions collected from ERLIC (25 fractions) and 
SCX (10 fractions), and as well as the fact the total amount of starting materials that went on each 
column were different. During analysis of MS/MS data, some overlaps of different subset of 
peptides were observed in samples from ERLIC and SCX approaches. 
SDS-PAGE gel LC-MS/MS approach 
Tris-Tricine/Urea gels have been commonly used for protein separation in the mass range 1-100 
kDa, especially for the resolution of proteins smaller than 30 kDa (Schägger, 2006). 10% 
acrylamide gels have been shown to have rapid separation and relatively wide mass range coverage 
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(2-100 kDa) (Schägger, 2006). As the resolution power of Tris-Tricine/Urea gels increases for small 
proteins with increased acrylamide concentration, 16% acrylamide gels were used in these 
experiments. Since excess urea can reduce the electrophoretic mobility, and as well as cause 
oligomerisation in membrane proteins, the concentration of urea under 6 M is recommended 
(Schägger, 2006). Therefore, 6 M of urea was used in my experiment. After separation of HEK293 
or HeLa proteins on Tris-Tricine SDS-PAGE gels the gels were then stained with Coomassie Blue 
G250 to detect protein bands. By using 16% acrylamide gels, excellent separation of protein <20 
kDa was obtained as illustrated in Figure 3.9. In order to increase total protein available for 
LC-MS/MS, multiple lanes of protein lysates were run in gels. 
 
Figure 3.7. Protein products identification via ERLIC and SCX 
The number of protein products obtained from HEK293 cell lysates via ERLIC and SCX 
fractionation in different rounds of attempts were calculated. From the results, the number of 
protein products obtained via ERLIC fractionation is relatively more than that via SCX when 1 mg 
of protein was used as the starting material for both approaches. The average value is based on 10 
distinct experiments. 
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Figure 3.8. Comparison of protein products identification via ERLIC and SCX 
Protein products identification from HEK293 cell lysates fractionated via ERLIC was ~50% higher 
than that via SCX. The average value is based on 10 distinct trials through ERLIC and 
SCX. Standard error of the mean was displayed in the error bar. 
The efficiency of these peptide enrichment strategies performed in my experiments was analysed by 
comparing the identification of protein products after LC-MS/MS analysis. From the resulting 
MS/MS data, 1515 protein products on average yielded from ERLIC approach while only 885 
protein products on average were obtained from the SDS-PAGE gel approach (Figure 3.10). In the 
comparison between SCX and SDS-PAGE approach, 1008 protein products in average yielded from 
SCX approach while only 885 protein products in average yielded from SDS-PAGE gel approach 
(Figure 3.11). Overall, both ERLIC and SCX approaches resulted more protein products from the 
same amount of starting material than that from SDS-PAGE gel approach. In addition, in my 
MS/MS data, more sPEPs were identified from ERLIC and SCX approaches than SDS-PAGE gel 
approach. 
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Figure 3.9. Results of SDS-PAGE gel electrophoresis in HEK293 cell lysates 
Proteins that less than 20 kDa molecular weights were excised from the gels in four sections: 15-20 
kDa, 10-15 kDa, 3.5-10 kDa, and those less than 3.5 kDa as illustrated. Gel pieces were diced into 
1-2 mm pieces and transferred into 1.5 ml Eppendorf tubes, followed by de-staining with 50% 
ACN/ 50 mM ABC to remove Coomassie Blue. 
  
Lane     1.   2.    3.    4.    5.    6.    7.    8.    9.    10. 
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Figure 3.10. Analysis of peptide enrichment strategies- ERLIC vs. SDS-PAGE 
The efficiency of these peptide enrichment strategies performed in my experiments was analysed by 
comparing the identification of protein products after LC-MS/MS analysis. From the resulting 
MS/MS data, 1515 protein products in average yielded from ERLIC approach while only 885 
protein products in average yielded from SDS-PAGE gel approach. Standard error of the mean was 
displayed in the error bar. 
 
Figure 3.11. Analysis of peptide enrichment strategies- SCX vs. SDS-PAGE 
The efficiency of these peptide enrichment strategies performed in my experiments was analysed by 
comparing the identification of protein products after LC-MS/MS analysis. From the resulting 
MS/MS data, 1008 protein products in average yielded from SCX approach while only 885 protein 
products in average yielded from SDS-PAGE gel approach. Standard error of the mean was 
displayed in the error bar. 
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MS analysis 
LC-MS/MS proteomics had been reported to enrich small polypeptides (Tinoco et al., 2010). Since 
the optimal size of polypeptides for LC-MS/MS detection is approximately 10 to 20 amino acids, 
trypsin digest has been reported (Slavoff, Mitchell et al. 2013) as a critical step for high sensitivity 
peptide detection because the average size of the tryptic peptides generated are about the right size 
(less than 50 amino acids in length) for MS analysis. 
To identify sPEPs, first, the resulting MS/MS data was searched against the SwissProt using 
MASCOT to filter out known proteins, and all unmatched spectra were further searched against the 
human RefSeq database. Any peptide spectrum matches (PSMs) with a score less than 40 were 
discarded since the likelihood that of a false positive increases as the score decreases. The 
remaining MS/MS data matched in human RNA database were examined manually to confirm that 
they met the criteria for a sPEP. The set of criteria includes: 1) a sequence tag of five consecutive b 
or y ions, 2) a precursor mass error of <50 ppm, 3) excellent sequence coverage. Using these 
criteria, nearly 50% of the remaining peptides were discarded. Peptides that met the criteria were 
then searched to determine whether they are translated in the correct reading frame by performing. 
tBLASTn searches for these translated sPEPs to determine their location in the corresponding gene 
sequence. Only those sPEPs positioned outside and / or out of the main CDS were collected for 
further analysis. After these examinations, approximately 1% of the remaining sPEPs remained 
from the candidate set. These MS/MS spectra were validated manually for the final confirmation of 
sPEP identification. 
To identify sPEPs missed by MASCOT and also to check for post-translational modifications 
(PTMs) which is limited in MASCOT searches due to the algorithm used, those MS/MS data 
filtered after SwissProt searches were also analysed against RefSeq Human RNA database and 
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cross-checked against HaltORF database (Vanderperre et al., 2012) using ProteinPilotTM𝑣4.5. 
Lastly, to determine if sPEPs had been identified previously in proteomic studies, sORFs were 
analysed against our in-house sORFs list, which contains all sORFs identified up to date.  
In this project, 1,879,681 MS/MS spectra were obtained in my experiments. The MS/MS data 
matched in human RNA database were examined to confirm that they met the criteria for a sPEP. 
Those MS/MS spectra that match main ORFs in SwissProt were excluded and everything else was 
re-searched in the RefSeq database, and this gave out more than 12,000 protein products (ORF hits) 
in the resulting pool. Any peptide spectrum matches (PSMs) with a score less than 40 were 
discarded, and it gave out more than 6,000 sORF after the analysis (Table 3.1). To identify those 
protein products, the sORFs were examined by hand according to the high score obtained in 
MASCOT algorithm with low error values, and well-matched MS/MS spectrum in b- and/or y-ion 
coverage. In addition, the predicted peptide sequence should not sit in the mCDS of a gene, 
determined by conducting tBLASTn (NCBI) searches. From the protein products analysed in 
MASCOT, eight sORFs have been identified and 11 distinct sPEPs matching back to those eight 
sORFs have been observed. Three of these have been confirmed as novel sPEPs (Table 3.2). From 
the searches in ProteinPilotTM𝑣4.5, two sPEPs were identified and which were also found in 
MASCOT searches. The MS/MS raw data of those sPEPs are shown in Figure 3.12. Among these 
sPEPs, five sPEPs are encoded from uORFs, two sPEPs are from ncRNAs, and four sPEPs are 
encoded from oORFs. Results showed that some of those 11 sPEPs have appeared reproducibly in 
different cell batches throughout the experiments. This result increases the confidence of sPEP 
confirmation and identification.	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 Number 
Total number of MS/MS spectra (SwissProt) 1,879,681 
Forwarded to the Human_RNA database 1,853,964 
Protein products matched after SwissProt search 13,928 (includes duplicates) 
Protein products matched after Human_RNA search 12,028 (includes duplicates) 
Peptide sequences matched after MASCOT score >40 6,204 (includes duplicates) 
sORFs identified through MASCOT search 8 (NM_019048.2; NR_003608.1; NM_015532.3; 
NM_080670.2; NM_004540.3; NR_024006.1; 
NM_020123.3; NM_007039.3) 
sPEPs identified through MASCOT search 11 (NM_019048.2; NR_003608.1; NM_015532.3; 
NM_080670.2; NM_004540.3; NR_024006.1; 
NM_020123.3; NM_007039.3) 
Protein products found through  ProteinPilotTM 19,440(includes duplicates) 
sPEPs identified through ProteinPilotTM 2 (NM_019048.2)  
Table 3.1. Supplementary data of MS/MS results. 
 
Gene name (NCBI) Peptide Sequence (Actual peptides identified in this project are highlighted in 
red) 
NM_019048.2 Homo sapiens 
asparagine synthetase domain 
MPSRGTRPEDSSVLIPTDNSTPHKEDLSSKIKEQKIVVDELSNLKKNRKV
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containing 1 (ASNSD1),mRNA YRQQQNSNIFFLADRTEMLSESKNILDELKKEYQEIENLDKTKIKK 
(Also identified by(Slavoff et al., 2013, Oyama et al., 2007) 
NM_019048.2 Homo sapiens 
asparagine synthetase domain 
containing 1 (ASNSD1),mRNA 
MPSRGTRPEDSSVLIPTDNSTPHKEDLSSKIKEQKIVVDELSNLKKNRKV
YRQQQNSNIFFLADRTEMLSESKNILDELKKEYQEIENLDKTKIKK 
(Also identified by(Slavoff et al., 2013, Oyama et al., 2007) 
NM_019048.2 Homo sapiens 
asparagine synthetase domain 
containing 1 (ASNSD1),mRNA 
MPSRGTRPEDSSVLIPTDNSTPHKEDLSSKIKEQKIVVDELSNLKKNRKV
YRQQQNSNIFFLADRTEMLSESKNILDELKKEYQEIENLDKTKIKK 
(Also identified by (Slavoff et al., 2013, Oyama et al., 2007) 
NM_019048.2 Homo sapiens 
asparagine synthetase domain 
containing 1 (ASNSD1),mRNA 
MPSRGTRPEDSSVLIPTDNSTPHKEDLSSKIKEQKIVVDELSNLKKNRKV
YRQQQNSNIFFLADRTEMLSESKNILDELKKEYQEIENLDKTKIKK 
(Also identified by(Slavoff et al., 2013, Oyama et al., 2007) 
NR_003608.1 Homo sapiens 
tubulin, alpha 3f, pseudogene 
(TUBA3FP), non-coding RNA 
MSGSCQRSGEDKKQEEEATAACGRLA 
GVPEAKQGPKADSDSDLETEGARGRGQARLLPLGASPAGVVGGGLAPP
RRQETSVQQGT  
(Also identified by(Slavoff et al., 2013) 
NM_015532.3 Homo sapiens 
polymerase (RNA) II (DNA 
directed) polypeptide M 
(POLR2M), transcript variant 1, 
mRNA 
MATPARAPESPPSADPALVAGPAEEAECPPPRQPQPAQNVLAAPRLRAP
SSRGLGAAEFGGAAGNVEAPGETFAQRKIHLQIARQR  
(Identified by (Oyama et al., 2007) 
NM_080670.2 Homo sapiens 
solute carrier family 35, member 
A4 (SLC35A4), mRNA 
MADDKDSLPKLKDLAFLKNQLESLQRRVEDEVNSGVGQDGSLLSSPFL
KGFLAGYVVAKLRASAVLGFAVGTCTGIYAAQAYAVPNVEKTLRDYL
QLLRKGPD  
(Identified by Wilson Ng, our research group 2012) 
NM_004540.3 Homo sapiens 
neural cell adhesion molecule 2 
(NCAM2), mRNA 
MTVKLQAELEGIKRACTLILNMPPSLYQTKQFITLGKEILSI 
(Identified by (Vanderperre et al., 2013) 
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NR_024006.1 Homo sapiens 
uncharacterized LOC92973 
(FP588) (LINC000950), 
non-coding RNA 
ISNGSDEISLP 
(Novel peptide) 
NM_020123.3 Homo sapiens 
transmembrane 9 superfamily 
member 3 (TM9SF3), mRNA 
ATAAAEEAAAGPGPVR 
(Novel peptide) 
NM_007039.3 Homo sapiens 
protein tyrosine phosphatase, 
non-receptor type 21 (PTPN21), 
mRNA 
MGLYCHTGTITEYLSRFLADGMGTGNCNYSNGDSRRGGWKGEEL 
(Novel peptide) 
Table 3.2. 11 sPEPs identified from proteomic and peptidomic process in this project. 
 
 
A) MS/MS spectrum of the sPEP identified by proteomic procedure matching the peptide 
IVVDELSNLK, found in the uORF of ASNSD1 mRNA sequence. 
A K     L    N    S    L    E     D    V  V 
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B) MS/MS spectrum of the sPEP identified by proteomic procedure matching the peptide 
NILDELK, found in the uORF of ASNSD1 mRNA sequence. 
 
 
C) MS/MS spectrum of the sPEP identified by proteomic procedure matching the peptide 
QQQNSNIFFALDR, found in the uORF of ASNSD1 mRNA sequence. 
      K       L        E       D      L      I 
      R     A   L   F    F  I   N  S  N   Q  Q        
L      I 
B 
C 
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D) MS/MS spectrum of the sPEP identified by proteomic procedure matching the peptide 
EYQEIENLDK, found in the uORF of ASNSD1 mRNA sequence. 
 
 
E) MS/MS spectrum of the sPEP identified by proteomic procedure matching the peptide 
LLPLGASPAGVVGGGLAPPR, found in TUBA3FP ncRNA sequence 
E P  P A    G   G V  VG  A P  S A G  L  P 
  K     D     L     N     E     I      E      Q D 
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F) MS/MS spectrum of the sPEP identified by proteomic procedure matching the peptide 
QPQPAQNVLAAPR, found in the uORF of POLR2M mRNA sequence. 
 
 
G) MS/MS spectrum of the sPEP identified by proteomic procedure matching the peptide 
GFLAGYVVAK, found in the oORF of SLC35A4 mRNA sequence. 
F            P  A A   L   V   N   Q  A  P   Q   P 
K	   	   	   	   A	   	   	   	   	   	   V	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   G	   	   	   	   A	   	   	   	   	   	   	   L	  G 
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H) MS/MS spectrum of the sPEP identified by proteomic procedure matching the peptide 
LQAELEGIK, derived from the oORF of NCAM2 mRNA sequence. 
 
 
I) MS/MS spectrum of the sPEP identified by proteomic procedure matching the peptide 
ISNGSDEISLP, derived from LINC00950 long ncRNA. 
I 
H 
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J) MS/MS spectrum of the sPEP identified by proteomic procedure matching the peptide 
ATAAAEEAAAGPGPVR, found in the oORF of TM9SF3 mRNA sequence. 
 
 
K) MS/MS spectrum of the sPEP identified by proteomic procedure matching the peptide 
GTITEYLSR, found in the oORF of PTPN21 mRNA sequence. 
J 
K 
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Figure 3.12. The MS/MS raw data & tables of sequence matches from fragment ions of the 
identified sPEPs. 
A) MS/MS spectrum of the sPEP, IVVDELSNLK, found in the uORF of ASNSD1 mRNA sequence. 
B) MS/MS spectrum of the sPEP, NILDELK, found in the uORF of ASNSD1 mRNA sequence. C) 
MS/MS spectrum of the sPEP, QQQNSNIFFALDR, found in the uORF of ASNSD1 mRNA 
sequence. D) MS/MS spectrum of the sPEP, EYQEIENLDK, found in the uORF of ASNSD1 
mRNA sequence. E) MS/MS spectrum of the sPEP, LLPLGASPAGVVGGGLAPPR, found in 
TUBA3FP ncRNA sequence. F) MS/MS spectrum of the sPEP, QPQPAQNVLAAPR, found in the 
uORF of POLR2M mRNA sequence. G) MS/MS spectrum of the sPEPE, GFLAGYVVAK, found 
in the oORF of SLC35A4 mRNA sequence. H) MS/MS spectrum of the sPEP, LQAELEGIK, 
derived from the oORF of NCAM2 mRNA sequence. I) MS/MS spectrum of the sPEP, 
ISNGSDEISLP, derived from LINC00950 long ncRNA. J) MS/MS spectrum of the sPEP, 
ATAAAEEAAAGPGPVR, found in the oORF of TM9SF3 mRNA sequence. K) MS/MS spectrum 
of the sPEP, GTITEYLSR, found in the oORF of PTPN21 mRNA sequence. 
Discussion 
Experiments had been performed repeatedly with minor changes in the protocol, including cell 
culturing and protein enrichment strategies to reconfirm those sPEPs found in previous experiments 
and also to obtain more data for sPEP identification. In order to prevent protein degradation during 
cell lysis, 8-hour 50 µM PI treatment was applied on HEK293 cells while 4-hour 50 µM PI was 
treated in HeLa cells before lysis. Results showed that the amount of protein products obtained was 
doubled in both HeLa and HEK293 cells with 50 µM PI treatment (Figure 3.4 & 3.5). From the 
results of protein identification in MASCOT searches, no significant increase in sPEP detection in 
both cell lines with PI treatment (Figure 3.6). In the results of MS/MS analysis, the same sPEP 
(peptide sequence: ISNGSDEISLP, derived from LINC00950 long ncRNA) appeared from the 
samples with and without PI treatment. Results indicated that PI treatment in cells could benefit in 
protein yield and it also supported that PI bortezomib does interfere with protein degradation 
(Gelman et al., 2013). However, in my result, the efficiency in sPEP identification after the use of 
PI bortezomib had no noticeable increase in the amount of protein yield. This may be due to the loss 
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of protein during protein separation processes, or the availability in the detection of peptides in 
LC-MS/MS analysis. 
Among the 11 identified sPEPs in my result, three of these have been confirmed as novel sPEPs. 
The role of these novel sPEPs remains unknown. Therefore, further characterisation of these sPEPs 
would be beneficial to explore their potential function. 
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Chapter 4 
Results from bioinformatic approaches 
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Introduction 
Bioinformatic analyses provide critical information for genes or proteins of interest by predicting 
the function of actual gene products. There are various bioinformatic tools for data analysis. For 
example, in molecular biology, tools which are designed to predict the secondary structure of a 
protein provides essential intermediate information on the way to predicting the full 3-D structure of 
a protein, and hence to predicting its function. Cross-species conservation of sORFs can reveal 
those that encode potential functionally important peptides, since high levels of sequence identity 
between sORF orthologues are an indication that their encoded uPEP has been maintained during 
evolution (Crowe et al., 2006).	  
Analysis of sORFs for cross-species conservation 
sORFs identified in both bioinformatic and proteomic studies were analysed for conservations in 
other species using both of Blast NCBI and uPEPperoni online tools, which detect conserved 
uORFs in eukaryotic transcripts. A NCBI BLAST search of both nucleotide and amino acid 
sequences of the sPEP from LINC00950 ncRNA revealed conservation between human, mouse, rat, 
and zebra-fish (Appendix 3a). The sPEP from the uORF of TM9SF3 was found to be conserved in 
human, mouse, bovine, and macaque (Appendix 3b), while the other sPEP from oORF of PTPN21 
showed conservations between human, mouse and rat (Appendix 3c). The high degree of 
conservation suggests that these sPEPs could be functional.  
Bioinformatic analysis of the characterisation of the novel sORFs 
Characterisation of the identified sORFs was obtained using a web-based peptide/protein analysis 
tool to look at properties of the sPEP such as protein hydrophobicity, transmembrane region 
predictions, and protein flexibility (Figure 4.1 - 4.3). Characterisation supports the potential that 
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these novel sPEPs can be bioactive and functional in cells due to particular features that are 
representative to be functional peptides such as having amphiphilicity helices, transmembrane 
regions (Appendix 4). Proteins play a significant role in biological processes by various folding 
possibilities. The prediction of a protein’s secondary structure is an essential intermediate step on 
the way to predicting the full 3-D structure of a protein by packing secondary structure elements 
into globular domains (Chen and Lonardi, 2009). Therefore, secondary structure predictions of the 3 
novel sPEPs have been analysed by bioinformatic tools. From the results, the low prediction 
confidence for the secondary structure of the sPEPs obtained through Phyer! could be due to the 
short peptide sequence used for query searches (Appendix 5). Protein localisation prediction of 
these sPEPs was analysed using protein structure prediction on the web: The PredictProtein server 
Rost, LocTree2, which predicts the subcellular localisation of all domains (Appendix 6). The novel 
sPEP from LINC00950 ncRNA is expected to be secreted. The sPEP from uORF of TM9SF3 is 
predicted to localise to the cytoplasm while the sPEP from oORF of PTPN21 is expected to be 
secreted. 
Gene expression in cells plays an important in the investigation of the synthesis of a functional 
product. Protein expression of the novel sPEPs identified in this project was analysed using a 
web-based gene and protein function analysis tool: BioGPF. From the results, LINC00950 ncRNA 
is found mainly in the superior cervical ganglion (Appendix 7a), which gives the protein expression 
prediction of the novel sPEP from this ncRNA. The sPEP from uORF of TM9SF3 (Appendix 7b) is 
predicted to have high expression in the colon while the sPEP from oORF of PTPN21 is predicted 
to be associated in the functions in cardiac myocytes, lymphoma, and liver (Appendix 7c). Protein 
motifs are small elements that are often used to predict protein function. Motifs are conserved 
among different proteins and may have structural or functional roles. Motif prediction for the three 
novel sPEPs were performed using MyHit, a database website, which analyses a protein sequence 
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for the known motifs through the program PROSITE. The LINC00950 sPEP sequence analysed has 
a potential N-glycosylation site at amino acid 29 (Appendix 8a). For TM9SF3 sPEP, it shows a 
strong match in the PROSITE database to have a potential alanine-rich region profile at amino acid 
9 (Appendix 8b). The result for this sPEP also shows several weak matches to have amidation sites, 
N-myristoylation sites, and protein kinase C phosphorylation sites. The PTPN21 sPEP sequence 
analysed shows a potential N-glycosylation site at amino acid 28, two casein kinase II 
phosphorylation sites at amino acid 9 & 30, two N-myristoylation sites at amino acid 21 & 37, and 
a and protein kinase C phosphorylation at amino acid 34 (Appendix 8c). With these potential 
chemical groups in sPEPs, it may imply that these sPEPs could be functional and associated in 
biological mechanisms, such as altering protein folding and stability; thus, regulating of protein 
function. 
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Figure 4.1. Predictions of hydrophobicity, hydrophilicity, and flexibility of the sPEP from 
LINC00950 ncRNA 
A) The graph is used to find clusters of hydrophobic amino acids or find potential antigenic sites of 
globular proteins. The transmembrane regions or antigenic regions of the peptide are seen as 
distinct peaks in the graph (labeled in black circles). B) This graph shows the prediction of the 
surface and flexibility properties regions of the sPEP from LINC00950 ncRNA. The sum of six 
fractional probabilities of the amino acids in the window are taken at once and divided by six to 
yield a running average of the fractional surface probability along the length of the protein. A value 
of 1.0 at any point (which will never occur) would mean that the hexapeptide centered about that 
point is definitely exposed at the surface of the protein and a value of 0.0 (which also will never 
B 
C 
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occur) means that the hexapeptide is definitely buried in the interior of the peptide. For this peptide, 
the hexapeptide is in the intermediate area of the protein. C) The average flexibility of a protein is 
1.0. Regions with values greater than 1.0 are predicted to be more flexible and values below 1.0 
indicate regions predicted to be less flexible as compared to average flexibility of the protein. There 
are two distinct regions (labeled in black circles) of this peptide that are predicted to be have 
average flexibility. 
 
 
 
 
 
A 
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Figure 4.2. Predictions of hydrophobicity, hydrophilicity, and flexibility of the sPEP from the 
uORF of TM9SF3 
A) The graph is used to find clusters of hydrophobic amino acids or find potential antigenic sites of 
globular proteins. The transmembrane regions or antigenic regions of the peptide are seen as 
distinct peaks in the graph (labeled in black circles). B) This graph shows the prediction of the 
surface and flexibility properties regions of the sPEP from the uORF of TM9SF3. The sum of six 
fractional probabilities of the amino acids in the window are taken at once and divided by six to 
yield a running average of the fractional surface probability along the length of the protein. A value 
of 1.0 at any point (which will never occur) would mean that the hexapeptide centered about that 
point is definitely exposed at the surface of the protein and a value of 0.0 (which also will never 
occur) means that the hexapeptide is definitely buried in the interior of the peptide. For this peptide, 
the hexapeptide is in the intermediate area of the protein. C) The average flexibility of a protein is 
1.0. Regions with values greater than 1.0 are predicted to be more flexible and values below 1.0 
indicate regions predicted to be less flexible as compared to average flexibility of the protein. There 
are five distinct regions (labeled in black circles) of this peptide that are predicted to be have 
average flexibility. 
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Figure 4.3. Predictions of hydrophobicity, hydrophilicity, and flexibility of the sPEP from the 
oORF of PTPN21 
A) The graph is used to find clusters of hydrophobic amino acids or find potential antigenic sites of 
globular proteins. The transmembrane regions or antigenic regions of the peptide are seen as 
distinct peaks in the graph (labeled in black circle). B) This graph shows the prediction of the 
surface and flexibility properties regions of the sPEP from the oORF of PTPN21. The sum of six 
fractional probabilities of the amino acids in the window are taken at once and divided by six to 
yield a running average of the fractional surface probability along the length of the protein. A value 
of 1.0 at any point (which will never occur) would mean that the hexapeptide centered about that 
point is definitely exposed at the surface of the protein and a value of 0.0 (which also will never 
occur) means that the hexapeptide is definitely buried in the interior of the peptide. For this peptide, 
the hexapeptide is in the intermediate area of the protein. C) The average flexibility of a protein is 
1.0. Regions with values greater than 1.0 are predicted to be more flexible and values below 1.0 
indicate regions predicted to be less flexible as compared to average flexibility of the protein. There 
are three distinct regions (labeled in black circles) of this peptide that are predicted to be have 
average flexibility. 
C 
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Analysis of CGG-repeat uORFs in neural transcripts 
Tandem repeats are common features of the genomes of prokaryotes and eukaryotes. They can be 
found in intergenic regions and also have been found in both non-coding and coding regions of 
different gene transcripts (Subirana and Messeguer, 2008). A number of human neurological 
disorders have been shown in association with nucleotide repeat expansions (Orr and Zoghbi, 2007). 
These dynamic mutations cause diseases by protein gain-of-function, protein loss-of-function, or 
RNA gain-of-function mechanisms and may occur in promoters, coding regions, introns and the 
5'leader and 3'trailer regions of mRNAs (McMurray, 2010). For example, expansion of a CGG 
nucleotide repeat (55-200) in the 5' UTR or promoter regions of the human FMR1 gene have been 
reported in association with Fragile X-associated Tremor Ataxia Syndrome (FXTAS), an inherited 
mental retardation (Penagarikano et al., 2007). 
To explore traces of conservation between human CGG-repeat uORFs in neural transcripts with 
different species, uORFs (a neural uORF list from John Carson, Connecticut) containing 
CGG-repeat elements were analysed using uPEPperoni online search engine, which detects 
conserved uORFs in eukaryotic transcripts. There are 23 hits of conserved uPEPs in other species 
obtained in total 226 human neural uORFs from the list (Appendix 9). Examples from uPEPperoni 
were shown in Figure 4.4. uPEPperoni also provides a Ka/Ks ratio to discover the evidence of 
purifying, positive or neutral selection. In this tool, sequences can be required to be of similar 
length or located in the same position relative to a previously identified ORFs. Further analyses of 
these sPEPs are required for characterisation. 
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Figure 4.4. Example output showing the heatmaps produced by querying the mRNA sequence 
of the Homo sapiens B4GALT2 transcript (NM_030587) against Mus musculus 
B4GALT2transcript variant 1 (NM_001253381) and transcript variant 2 (NM_017377) 
analysed from uPEPperoni online search engine 
The black bars above the heatmap indicate the ORFs on the transcript. The output lists the most 
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conserved uPEPs first. The heatmap generated by the query sequence is shown first, followed by 
the reciprocal heatmap generated using the reference sequence (mouse B4GALT2 transcript). The 
unformatted aligned sequence can be viewed using a hyperlink shown above the heatmap. 
uPEPperoni also provides Ka/Ks ratio for potential protein coding regions prediction (Skarshewski 
et al., 2014). 
Analysis of sPEPs with four or more Cys residues 
Cysteine is often found in the functional sites in proteins, participating in catalytic, regulatory, 
cofactor-binding, structure-stabilizing functions (Marino and Gladyshev, 2012, Tiessen et al., 2012). 
Cys mutations have been reported in association with the connections between human genetic 
diseases and evolution (Wu et al., 2007). To explore traces of bioactive sPEPs, sPEPs identified in 
both bioinformtic and proteomic studies were analysed for the presence of four or more Cys 
residues in sequence (Table 4.1). Five Cys residues were found to be prevalent in these sPEPs, 
followed by four and six Cys residues. Only one sPEP had 12 Cys residues (Figure 4.5). There are 
several methods that can be used to examine Cys reactivity, such as pKa measurements by 
identifying Cys residues with heightened nucleophilicity. However, this method may not be suitable 
for a proteomic scale because it requires purified protein and detailed kinetic and mutagenic 
experiments (Quantitative reactivity profiling predicts functional cysteines in proteomes). 
Alternative methods have been reported to predict redox-active cysteine computationally by 
identifying Cys with specific modifications (Sethuraman et al., 2004). Based on these methods, 
examination of those sPEPs containing four or more Cys is worthy for further investigation. 
Discussion 
Cross-species conservation of sORFs can reveal those that encode potential functionally important 
peptides, since high levels of sequence identity between sORF orthologues are an indication that 
their encoded uPEP has been maintained during evolution (Crowe et al., 2006). uPEPperoni also 
provides a Ka/Ks ratio to discover the evidence of purifying, positive or neutral 
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selection(Skarshewski et al., 2014). In this tool, sequences can be required to be of similar length or 
located in the same position relative to a previously identified ORFs. sORFs that lack cross-species 
conservation have been reported to be more likely random sequences without encoding for 
functional peptides (Andrews and Rothnagel, 2014). Therefore, it is important to obtain evidence of 
evolutionary conservation as a predictor of function. However, non-conserved sORFs are still 
worthy to be retained for further analyses since species-specific sPEPs may also be biologically 
relevant.	  
Although sPEPs can be identified bioinformatically, their function in cell biology needs more 
investigation. In order to understand the functionality of the identified sPEPs, characterisation 
through cellular and bioinformatic tools is essential. Computational biology is often used in 
predicting structures, membrane organisation or localisation signal of sPEPs. Complementary DNA 
of these sPEP sequences could be isolated and sequenced to observe their expression at both mRNA 
and protein levels. In particular, subcellular localisation of these sPEPs could be investigated 
through immunostaining experiments and using specific antibodies or fluorescent tags. Western blot 
and enhanced MS studies could be also implemented to explore the posttranslational processing of 
the identified sPEPs.  
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Figure 4.5. The prevalence of Cys residues contained in identified sPEPs 
There are four Cys residues found in 8 sPEPs of the identified sPEPs, five Cys residues found in 
eight sPEPs, and six Cys residues in 3 sPEPs. Only one sPEP has 12 Cys residues. 
 
NCBI Accession 
number 
Chr Strand Coordinate gene name 
Coordinate start-stop 
codon 
uORF 
start-end 
Peptide sequence 
     
NM_007106_1 13 - 
Homo sapiens ubiquitin-like 3 
(UBL3), mRNA 
29849867-29849805 817-882 
MSVCHSARSTWRGR
SWGCCCC      
NM_015457_4 11 + 
Homo sapiens zinc finger, 
DHHC-type containing 5 
(ZDHHC5), mRNA 
57672718-57672828 884-997 
MSCILICLTVHVFHL
QPFACVQPTVCLQFL
NCTSCVS 
NM_016192_2 2 - 
Homo sapiens transmembrane 
protein with EGF-like and two 
follistatin-like domains 2 
(TMEFF2), mRNA 
192814004-192814090 236-322 
MRGFGCCFPAGCHC
HRRRLCCRRPRDAQ 
NM_016513_1 6 - 
Homo sapiens intestinal cell 
(MAK-like) kinase (ICK), 
transcript variant 2, mRNA 
53041385-53041269 342-461 
MYLGDSHVLLNTLC
WCCHRKIWLHSGED
CYHCRTEPLRP 
NM_020665_1 X - 
Homo sapiens transmembrane 
protein 27 (TMEM27), 
mRNA 
15664849-15664751 183-284 
MAKADLSAAWIFFFS
LCLVFSTLKECCGCS
FFW 
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NM_024735_1 16 - 
Homo sapiens F-box protein 
31 (FBXO31), transcript 
variant 1, mRNA 
87360363-87347185 393-530 
MVFAKTCGSWRSQA
CLVGTSMRSCFTDID
TFWDCGSQISGHTED
C 
NM_138447_1 16 - 
Homo sapiens zinc finger 
protein 689 (ZNF689), 
transcript variant 1, mRNA 
30610351-30610214 36-176 
MALRSIKSIAGSCLCS
RQRRCGSSAAIFPEGI
FRCLSPKFGQEFPE 
NM_178011_4 10 + 
Homo sapiens leucine rich 
repeat transmembrane 
neuronal 3 (LRRTM3), 
mRNA 
66926327-66926536 294-506 
MKILLPRKILMFCCE
CGVGIYLFLECSAWL
AKNNVPKSVHLPRG
PIFLPGCQRALTHYS
AADRGCHATGP 
NM_031936.4 1 + 
Homo sapiens G 
protein-coupled receptor 61 
(GPR61), mRNA 
109542971-109543336 632-1000 
MGDGPVTGGTLGAL
FRPHGVLTHPPVIRE
LFHFGEGPSNPRSLY
CQWGPGGGATGCCF
GICGPLLHAPAGLDC
CGWQCRCDGRDRQ
DACPPKICLRLPPLPG
GPAGCPDPHAPGHA
LQLCPL 
NM_015282.2 2 - 
Homo sapiens cytoplasmic 
linker associated protein 1 
(CLASP1), transcript variant 
1, mRNA 
121606051-121605929 235-360 
MVHCCHSPDCIFETQ
ALSNLQRTKRQPPRY
VCWEGVIVTAL 
NM_080670.2 5 + 
Homo sapiens solute carrier 
family 35, member A4 
(SLC35A4), mRNA 
140566788-140566949 347-508 
MSSSAFRWRHFIWIP
QLSSICYLQLSCHLH
PCLPSCRLWTVVPQP
APWIPSSPS 
NM_002285.2 2 - 
Homo sapiens AF4/FMR2 
family, member 3 (AFF3), 
transcript variant 1, mRNA 
99551326-99551198 4064-4193 
MCVCMCGYIRSRLC
MCVR 
NM_019886.3 X + 
Homo sapiens carbohydrate 
(N-acetylglucosamine 6-O) 
sulfotransferase 7 (CHST7), 
mRNA 
46433686-46434177 494-986 
ARCATCCVRSSAATS
PCCGCTR 
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NM_182898.2 7 + 
Homo sapiens cAMP 
responsive element binding 
protein 5 (CREB5), transcript 
variant 1, mRNA 
28860728-28860865 3748-3886 
LDLLMCVCVCVCVC
VFMGFK 
NM_014780.4 6 - 
Homo sapiens cullin 7 
(CUL7), transcript variant 2, 
mRNA 
43018833-43017971 1408-1702 
MLCMCGTHCSRGCE
CGCWMIMRR 
NM_015089.2 6 + 
Homo sapiens cullin 9 
(CUL9), mRNA 
43154066-43155076 1198-1555 
MENMCSRHSSQGCE
CGCWMIMR 
NM_004265.3 11 + 
Homo sapiens fatty acid 
desaturase 2 (FADS2), 
transcript variant 1, mRNA 
61865736-61866005 1531-1801 
ARGMMGFCSEGCPR
GWCMHCSR 
NM_152312.3 11 + 
Homo sapiens 
glycosyltransferase-like 1B 
(GYLTL1B), mRNA 
45924226-45924588 551-686 MDGACCPCQLLSCR 
NM_144612.6 18 - 
Homo sapiens lipoxygenase 
homology domains 1 
(LOXHD1), transcript variant 
1, mRNA 
46547017-46546874 2704-2848 
MMASCPGSCCQWM
SPMCCHRAR;MMAS
CPGSCCQWMSPMCC
HR 
NM_003791.2 16 - 
Homo sapiens 
membrane-bound 
transcription factor peptidase, 
site 1 (MBTPS1), mRNA 
84066566-84065717 2777-2906 
MSCCLCGTWGSAM
ACMKGSSPWPTMTC
IMR 
NM_004959.4 9 - 
Homo sapiens nuclear 
receptor subfamily 5, group 
A, member 1 (NR5A1), 
mRNA 
124500613-124500077 533-1070 
TATQSPSLEGPTCLSS
SCSCCSWSRMR 
NM_020151.3 2 - 
Homo sapiens StAR-related 
lipid transfer (START) 
domain containing 7 
(STARD7), mRNA 
96185102-96184851 3141-3396 
MWMDVCIRERENM
CVCVCVCER 
Table 4.1. sPEPs identified in both bioinformtic and proteomic studies with the presence of 
four or more Cys residues in sequences 
sPEPs that contain four or more cystein residues were collected and arranged into a table listing 
their coordinate gene sequence (NCBI accession number), chromosomal location, DNA strand 
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orientation, the location of the start/stop codon of their coordinate sORF in chromosome, the 
location of the start/stop codon of their coordinate sORF, and the sPEP sequence identified in both 
bioinformatic and proteomic studies. 
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Chapter 5 
General Discussion 
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Introduction 
The aim of this project was to identify novel peptides that are translated from sORFs. We 
hypothesize that a subset of sORFs encode for functional sPEPs that are expressed and contribute to 
proteome complexity. Recent proteomic studies of endogenous proteins expressed in human cell 
lines have led to the discovery of novel sPEPs (Slavoff et al., 2013, Vanderperre et al., 2013). 
sPEPs are presumed to be small and of low abundance. In addition, the dynamic range and the 
complexity of the cellular proteome, such as post-translational modifications create challenges 
when sampling low abundant and small proteins (Nielsen et al., 2006). Therefore, it is necessary to 
develop effective, comprehensive, low-molecular-weight protein extraction methodologies to 
analyse endogenous proteins in a relatively complex and dynamic range of human cells. 
Mass spectrometry-based methodologies in peptide enrichment approaches have been proven to be 
an ideal analytical method for mapping of peptides (Zarei et al., 2011). However, due to sample 
complexity, fractionation of peptides prior to MS analysis is a critical step. Two different peptide 
fractionation strategies were evaluated in this project. Although ERLIC and SCX approaches were 
demonstrated to have the best performance for detecting low abundance proteins in my experiments, 
it is still difficult to comment whether sPEPs can be better extracted by one particular method. 
Overall, both ERLIC and SCX approaches resulted more protein products from the same amount of 
starting material than that from SDS-PAGE gel approach. However, the MS/MS results did not 
show more sPEP identification through ERLIC and SCX approaches than that through SDS-PAGE 
gel approach. In addition, the same sPEPs were found multiple times regardless of method. 
ERLIC has been shown to have better result in the separation of multi-phosphorylated peptides, 
while SCX is suited for the fractionation of mono-phosphorylated peptides (Zarei et al., 2012). A 
combination of ERLIC and SCX approach would increase the coverage of proteome analysis. As 
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the knowledge of endogenous sPEP expression is limited (structure, size, abundance etc.), 
combination of these peptide enrichment methods may be more favorable for sPEP detection in the 
future.  
Validation of protein extraction methods 
Molecular Weight Cut-Off (MWCO) + ERLIC (or SCX) approach 
ERLIC has been reported to have 36% more protein identifications than via SCX fractionation (Sze 
et al., 2010). Moreover, over 120% more highly hydrophobic and basic peptides were identified by 
ERLIC than SCX (Sze et al., 2010). The average amount of protein products yield from ERLIC and 
SCX was calculated for comparison (Figure 3.8). From the result, protein identification via ERLIC 
fractionation was ~50% higher than via SCX, indicating that ERLIC operates higher sensitivity in 
protein separation and identification. The total number of proteins identified in each experiment 
varied quite a lot which may be due to the differences in the protocols, including cell culturing (PI 
treatment) and peptide separation and extraction strategies. From the results, the number of protein 
products obtained via ERLIC fractionation is relatively more than that via SCX when 1 mg of 
protein was used as the starting material for both approaches. However, the difference in the protein 
product identification between ERLIC and SCX may be due to the different numbers of fractions 
collected from ERLIC (25 fractions) and SCX (10 fractions), and as well as the different amounts of 
starting materials that went on each column. 
ERLIC approach in enriching for peptides for MS-based identification has been reported to provide 
more advantages than the SCX approach (Gan et al., 2008). As the benefit by operating in a 
single-step for peptide fractionation with the potential of being incorporated into high-throughput 
automated processes, ERLIC has been shown higher efficiency at identifying low abundant peptides 
and provides better coverage of peptides with acidophilic motifs (Gan et al., 2008). In this project, 
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my data reveals that ERLIC and SCX approaches exploit different strategies for enrichment that 
share some overlaps of different subsets of peptides. Therefore, complementary operation of both 
approaches provides more comprehensive coverage of peptides. 
SDS-PAGE gel LC-MS/MS approach 
The efficiency of these peptide enrichment strategies performed in my experiments was analysed by 
comparing the identification of protein products after LC-MS/MS analysis. From the resulting 
MS/MS data, 1515 protein products on average yielded from ERLIC approach while only 885 
protein products on average were obtained from the SDS-PAGE gel approach (Figure 3.10) when 1 
mg of protein was used as the starting material for both approaches. In the comparison between 
SCX and SDS-PAGE approach, 1008 protein products in average yielded from SCX approach 
while only 885 protein products in average yielded from SDS-PAGE gel approach (Figure 3.11) 
when 100 μg of protein was used as the starting material for both approaches. Overall, from the 
MS/MS resulting data, both ERLIC and SCX approaches resulted more protein products from the 
same amount of starting material than that from SDS-PAGE gel approach. 
Since numerous variables were encountered during sample preparation such as gel excision 
procedures, and peptide purification skills, as well as that current MS analysis has not matured 
enough to reflect the actual effectiveness of protein enrichment strategies, these would be the major 
difficulties in sPEP identification. 
sPEP identification and characterization 
In this study, I identified eight sORFs and 11 distinct sPEPs ofthese 11 sPEPs, three have been 
confirmed as novel sPEPs (Table 3.2). To confirm the validity of these sPEPs, the scores in 
MASCOT and ProteinPilotTM, and the MS/MS spectrum in b- and/or y-ion coverage. In addition, 
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these sPEPs should sit out of the mCDS of a gene, determined by conducting tBLASTn (NCBI) 
searches. These sPEPs were then validated manually in the MS/MS spectra for the final 
confirmation of sPEP identification. 
Experiments had been performed repeatedly with minor changes in the protocol, including cell 
culturing and protein enrichment strategies to reconfirm those sPEPs found in previous experiments 
and also to obtain more data for sPEP identification. Results showed that some of those 11 sPEPs 
have appeared multiple times in different cell batches used throughout the experiments. This result 
increases the confidence of sPEP confirmation and identification. 
Two recent proteomic studies claimed to find several hundreds of sPEPs (Slavoff et al., 2013, 
Vanderperre et al., 2013) while only 11 sPEPs were detected in my project. Reasons for the large 
difference in the number of sPEP identifications between mine and other researchers were evaluated 
by the different materials and methods used in these studies. Firstly, several aliquots of 1 x 109 of 
starting materials with various types of human cell lines, tissues, and fluids were used in these 
studies. For example, in Slavoff’s group, HEK293T, HeLa, K562, COS7, and MEF cells were lysed 
to process polypeptides (Slavoff et al., 2013). Vanderperre et al. operated with more variety of 
starting materials by using HEK293, HeLa, human colon CCL227, CCL228, CCL233, CRL1459, 
and HCT116 cells, as well as human cancerous ovarian, normal ovarian, cancerous fallopian tube, 
normal endometrial, and lung tissues. They had also reviewed raw data published and made 
available by PeptideAtlas online repository (Desiere et al., 2006) from cerebrospinal fluid, plasma, 
and serum. They have been thorough in scrutinizing the data and observed that out-of-frame clones 
representing oORFs were mistakenly rejected as false positive in cDNA screening assays. In 
comparison, due to the limitation of the starting material, only several batches of 1 x 108 of 
HEK293 and HeLa cells were used in my project. Secondly, the methodology performed in my 
project was similar to that used in Slavoff et al. by using MWCO filters, followed by ERLIC 
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fractionation prior to MS/MS analysis. SDS-PAGE gel electrophoresis for protein separation was 
demonstrated in both studies and my project. SCX approach was performed as an alternative in my 
project. Based on the same amount of starting material, ERLIC resulted in higher efficiency at 
identifying low abundant peptides and provided better coverage of peptides among the approaches 
used in my project. In this project, results showed that ERLIC and SCX approaches exploit different 
strategies for enrichment that share some overlaps of different subsets of peptides. Therefore, 
complementary operation of both approaches provides more comprehensive coverage of peptides. 
All the 11 sORFs identified in my project were found through ERLIC approach and some of them 
were also found through SCX approach. In SDS-PAGE gel approach, none of sPEPs were 
identified. 
Although three novel sPEPs have been identified in my work, their role in gene expression and 
cellular function remains unknown. Further characterisation of these sPEPs would be beneficial to 
explore their potential in gene regulation. 
Conclusion and Future Directions 
Only a few endogenous sPEPs have been detected in human cell lines from MS studies suggesting 
low expression of sPEPs in those cells. The dynamic range and the complexity of the cellular 
proteome, such as post-translational modifications create challenges when sampling low abundant 
and small proteins (Nielsen et al., 2006). Therefore, efficient peptide enrichment strategies are 
important for detecting small proteins such as sPEPs with predicted low abundance. 
Moreover, the lack of information on sPEPs (eg. sub-cellular localization of the sPEPs, cell types 
expressed in) limits the ability to design an effective strategy that would be able to increase 
sensitivity of sPEP detection by LC-MS/MS. On the other hand, the limit in the detection of sPEPs 
may be due to MS/MS settings during analysis. The mass spectrometer was set to only find double 
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or triple charged peptides greater than m/z 350, which meant that only peptides of mass greater than 
700 Da could be detected. Therefore, many peptides were simply never observed. In addiion, due to 
algorithm limits in MASCOT (ie. “false negative” results in MASCOT and also the limit to check 
PTM), the MS/MS data were analysed through ProteinPilot!"against RefSeq Human RNA 
database and cross-checked with HaltORF database. 
In regard to the issue of MS analysis using MASCOT and ProteinPilot!", the y-ion coverage of 
peptide peaks often do not reach the maximum unless multiple analysis is attempted (Chong et al., 
2006). Therefore, samples from different cell batches were used and analysed by LC-MS/MS to 
increase the sequence coverage. Experiments had been performed repeatedly with minor changes in 
the protocol, including cell culturing and protein enrichment strategies to reconfirm those sPEPs 
found in previous experiments and also to obtain more data for sPEP identification. Results showed 
that some of those 11 sPEPs have appeared few times in different cell batches throughout the 
experiments. This result increases the confidence of sPEP confirmation and identification. 
A recent study reported that proteins of size 151-250 amino acids had higher frequency distribution 
than proteins of size 51-150 amino acids and even more than proteins of size ≤100 amino acids in 
eukaryotic genomes, indicating that it would be more difficult to predict biological roles in smaller 
proteins than larger ones although small proteins could have important biological functions (Tiessen 
et al., 2012). 
Ribosome profiling strategies have recently emerged as a powerful tool to map which mRNA 
transcripts are translated at any particular stage and at what efficiency (Kuersten et al., 2013). 
However, proteomic studies reporting post-translational regulation of proteins, protein 
modifications, protein isoforms and variability within populations indicate that the current paradigm 
is far from accurate (Cox and Mann, 2011). Thus, to overcome this issue is to describe this diversity 
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by integrating data for the various parameters that can be measured, although this is 
computationally challenging. 
Further direction to the project will be focused on chracterisation and in-cell localisation of these 
sPEPs to examine whether they are functional or whether they are simply unavoidable by-products 
of sORF cis-acting activities in cellular biology. The strategy designed for determining their 
functions is to overexpress candidate sPEPs in transfected cell lines or in whole organisms and 
monitor changes in phenotypes (Andrews and Rothnagel, 2014).  
In summary, eight sORFs and 11 distinct sPEPs encoded by these sORFs were identified through 
LC-MS/MS analysis in this project, and three of these have been confirmed as novel sPEPs. This 
finding supports the hypothesis that a fraction of sORFs encode functional peptides that are 
endogenously expressed as part of the cellular proteome. The identification of the uPEP in HeLa 
cells also confirmed the previous finding of the same uPEP in a different human cell line in our lab. 
The peptide enrichment strategy performed in this project revealed that both ERLIC and SCX 
approaches resulted more protein products than that from SDS-PAGE gel approach. In addition, 
results in this project showed that protein products identification via ERLIC was ~50% higher than 
that via SCX. However, this may not be regarded as reliable since the starting materials that went 
on each column were different, as well as to the different numbers of fractions collected from 
ERLIC (25 fractions) and SCX (10 fractions). Overall, both ERLIC and SCX approaches gave great 
results in peptide separation in this project. Further characterisation of these sPEPs is necessary and 
beneficial to explore their potential in gene regulation.  
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Appendix 1 
Table A1. Conservation of uORFs in difference species. 
Species with uORF sequence conservation  Number of conserved uORFs 
Human and mice (Crowe et al., 2006) 247 
Arabidopsis Thaliana and rice (Hayden 
and Jorgensen, 2007) 
15 
Rice, sorghum, wheat, maize, and barley 
(Tran et al., 2008) 
29 
Arabidopsis, grapevine, tobacco, soybeans, 
orange, and cotton (Vaughn et al., 2012) 
18 
Cryptococcus neoformans (Neafsey and 
Galagan, 2007) 
122 
Drosophila melanogaster and other 
dipteran EST sequences (Hayden and 
Bosco, 2008) 
44 
Human (Slavoff et al., 2013) 15 
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Table A2. Conservation of sORFs in bioinformatics studies. 
Reference Species involved  Number of 
putative coding 
sORFs 
Number of transcripts 
analyzed 
uORFs 
(Iacono et al., 
2005) 
Conservation of human and mouse uORFs. 43 27,660 (human) 
(Crowe et al., 
2006) 
Conserved uORFs between human and 
mouse; bias towards optimal Kozak 
sequences; evidence of purifying selection. 
204 21,768 (human) 
(Hayden and 
Bosco, 2008) 
Conserved uORFs between D. 
melanogaster, A. gambiae and EST 
sequences from D. simulans, D. yakuba, 
D. erecta, and D. ananassae; evidence of 
purifying selection. 
44 19,389 
(D. melanogaster) 
(Hayden and 
Jorgensen, 2007) 
Conserved uORFs between Arabidopsis 
and rice; four uORFs had conservation 
between others species; evidence of 
purifying selection. 
19  34,000 (Arabidopsis) 
(Tran et al., 2008) Conservation of uORFs between Rice, 
wheat, barley, maize, sorghum, and 
29 32,127 (rice) 
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Arabidopsis. 15 
(Takahashi et al., 
2012) 
Conserved uORFs in Arabidopsis based on 
analysis of EST sequences; evidence of 
purifying selection. 
18 27,101 (Arabidopsis) 
(Vaughn et al., 
2012) 
Conserved uORFs between Arabidopsis, 
tobacco, grapevine, soybeans, orange and 
cotton; evidence of purifying selection. 
18 10,122 
(Arabidopsis) 
(Zhang and 
Dietrich, 2005) 
Conserved uORFs between S. cerevisiae 
and S. paradoxus, S. bayanus, S. mikatae, 
S. kudriavzevii, S. kluyveri, S. castelii, A. 
gossypii, C. glabrata , K. lactis and K. 
waltii; evidence of transcription. 
19 5,542 (S. cerevisiae) 
(Cvijović et al., 
2007) 
Conserved uORFs between S. cerevisiae 
and at least one of the following fungual 
species; S. paradoxus, S. mikatae, S. 
bayanus, S. kudriavzevii, S, castellii or S. 
kluyveri. 
379 5,602 (S, cerevisiae) 
(Neafsey and 
Galagan, 2007) 
Conserved uORFs between the four 
Cryptococcus neoformans strains (JEC21, 
TIGR, WM276, and H99); evidence of 
purifying selection in 12 uORFs. 
122 2,167 (C. neoformans) 
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ncRNAs 
 
(Frith et al., 2006) sORFs in Mus musculus using CRITCA; 
evidence of conservation in rats and 
humans; evidence of transcription; 
evidence of localization. 
1,240 102,801 transcripts 
40,841 sORFs (mouse) 
(Ladoukakis et al., 
2011) 
Conserved ncRNAs between D. 
melanogaster and D. pseudoobscura; 
evidence of transcription; evidence of 
purifying selection; evidence of syntenic 
conservation. 
401 593,586 sORFs (D. 
melanogaster) 
(Hanada et al., 
2007) 
ncRNAs in Arabidopsis; evidence of 
transcription; evidence of conservation in 
B. oleracea, O. sativa, P. trichocarpa, M. 
truncatula or L. corniculatus; evidence of 
purifying selection. 
3,241 570,948 sORFs 
(Arabidopsis) 
(Hanada et al., 
2013) 
ncRNAs in Arabidopsis; evidence of 
transcription; evidence of conservation in 
P. patens, M. moellendorffii, Z. mays, S. 
bicolor, B. distachyon, O. sativa, M. 
guttatus, V. vinifera, R. communis, M. 
esculenta, P. trichocarpa, C. sativus, G. 
max, M. truncatula, C. papaya, or A. 
2,302 96,358 transcripts 
(Arabidopsis) 
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lyrata; evidence of purifying selection. 
(Lease and 
Walker, 2006) 
ncRNAs conserved between Arabidopsis 
and rice; evidence of transcription; 
evidence of clustering of potential gene 
families. 
1,044 606,285 sORFs 
(Arabidopsis) 
(Yang et al., 2011) ncRNAs in P. deltoids; evidence of 
conservation; evidence of coding potential; 
evidence of clustered peptide families; 
evidence of protein domains/motifs and 
evidence of expression via mass 
spectrometry. 
1,469 ~2.6 million ESTs 12,852 
sORFs 
(P. deltoids) 
(Kastenmayer et 
al., 2006) 
Characterised ncRNAs in Saccharomyces 
cerevisiae previously identified as putative 
coding sORFs based on evidence of 
transcription or translation. Further of 
evidence of conservation in S. pombe, C. 
elegans, A. thaliana, D. melanogaster, M. 
musculus or H. sapiens; evidence of 
functionality based on gene deletion 
experiments. 
299 N/A 
oORFS 
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(Chung et al., 
2007) 
Conserved oORFs between human, mice 
and rat or dog that are under purifying 
selection. 
40 14159 (human) 
(Ribrioux et al., 
2008) 
Conserved oORFs between human, mice 
and rat that contained Kozak sequences. 
215 9163 (human) 
(Xu et al., 2010) Conserved oORFs between human and 
mice. 
168 26009 (human) 
(Vanderperre et 
al., 2012a) 
oORFs on alternate reading frames from 
human mRNA that had strong Kozak 
sequences. 
24,547 ~76000 (human) 
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Table A3. Functional sPEPs. 
Species    
 
Genes or transcripts  Number of 
residues in 
sPEP  
Function 
Upstream sPEPs  
Arabidopsis 
thaliana  
GBF6 (Smeekens et 
al., 2010) 
28 Expression of the CDS is modulated by sucrose levels through a 
conserved sPEP  
SAMDC (Hanfrey et 
al., 2005) 
52 Expression of the CDS is regulated by polyamines binding to the 
nascent upstream sPEP; orthologous to human SAMDC  
XPL1 
(Alatorre-Cobos et al., 
2012) 
26 Expression of the CDS is regulated by phosphocholine binding to 
the sPEP  
Saccharomyce
s cerevisiae  
CPA1 (Werner et al., 
1987) 
25 The sPEP reduces expression of the CDS through ribosomal 
stalling and blocking translation in response to increased arginine 
levels  
Humans  ASS1 (Pendleton et 
al., 2005) 
44 The sPEP regulates expression of ASS1 in a trans-suppressive 
manner  
EPHX1 (Nguyen et 
al., 2013) 
17 & 26 Expression of EPHX1 is inhibited by trans-acting sPEPs that are 
encoded by two uORFs through interactions with the translation 
machinery  
HR (Wen et al., 2009) 34 The sPEP is implicated in the regulation of HR; 13 causative 
mutations of Marie Unna hereditary hypotrichosis have been 
identified within the second uORF  
MKKS (Akimoto et al, 
2013) 
63 & 50 Both sPEPs localize to the mitochondrial membrane and are 
predicted to function independently of MKKS  
NR3C1 (Diba et al., 
2001) 
93 The sPEP localizes to the cell membrane and regulates expression 
of the glucocorticoid receptor in a trans-acting manner through 
interaction with unknown cellular factors  
SAMDC (Law et al., 
2001) 
6 Expression of the CDS is regulated by polyamines binding to the 
nascent upstream sPEP; orthologous to A. thaliana SAMDC  
Intergenic sPEPs  
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A. thaliana  PLS (Casson et al., 
2002) 
36 The sPEP is required for correct auxin–cytokinin homeostasis to 
modulate root growth and leaf vascular patterning  
 ROT4 (Narita et al., 
2004) 
53 The sPEP is involved in regulation of leaf shape by reducing cell 
proliferation in lateral organs  
Drosophila 
melanogaster  
 
Ilp8 (Colombani et 
al., 2012) 
150 The sPEP provides a signal that promotes the delay of 
metamorphosis in response to conditions that that alter growth in 
imaginal discs  
HSPC300 (Qurashi et 
al., 2007) 
75 The sPEP is a component of the WAVE–SCAR complex and is 
important in nervous system development for axonogenesis and 
neuromuscular synapse morphogenesis; HSPC300 is orthologous 
to brk1  
 pgc 
(Hanyu-Nakamura et 
al., 2008) 
71 The sPEP is essential for repressing Ser2 phosphorylation in the 
carboxy-terminal domain of RNA polymerase II in newly formed 
pole cells (which are the early germline progenitors) and thus has a 
fundamental role in germ-cell specification  
 tal (Kondo et al., 
2010) 
11 & 32 The sORFs encode three peptides of 11 residues and one peptide of 
32 residues that are essential for embryonic development and that 
are required for formation of epithelial architecture; tal is 
orthologous to Mlpt  
 RanGAP (Magny et 
al., 2013) 
28 & 29 Both sPEPs are involved in the regulation of Ca2+ trafficking; 
alterations result in irregular muscle contractions  
Maize  brk1 (Frank and 
Smith, 2002) 
84 The sPEP promotes multiple actin-dependent cell polarization 
events in the developing leaf epidermis; brk1 is orthologous to 
HSPC300  
Soybean  ENOD40-1 (Röhrig et 
al., 2002) 
12 & 24 The sPEP binds to nodulin 100 (which is a subunit of sucrose 
synthase) and is likely to be involved in the control of sucrose use 
in nitrogen-fixing nodules  
Tribolium 
castaneum  
Mlpt (Savard et al., 
2006) 
10, 11, 15 & 23 The sORFs encode four sPEPs with roles in embryonic 
development, particularly the development of abdominal segments; 
Mlpt is orthologous to tal  
Overlapping sPEPs and downstream sPEPs 
Humans  TYRP1 (Wang et al., 
1996) 
24 The sPEP is co-expressed from the TYRP1 transcript  
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CASP1 (Ronsin et al., 
1999) 
151 The sPEP is expressed from the intestinal carboxyl esterase gene 
and is recognized by human leukocyte antigen-B7-restricted renal 
cell carcinoma-reactive T cell clone  
AltPrP (Vanderperre 
et al., 2011) 
73 The sPEP is co-expressed from the prion protein transcript in brain 
homogenates, primary neurons and peripheral blood mononuclear 
cells; it localizes to the mitochondria  
AltATXN1 (Bergeron 
et al., 2013) 
185 The sPEP is co-expressed from the ATXN1 transcript and is 
expressed in the cerebellum; it colocalizes and interacts with the 
ATXN1 protein in the nucleus  
AltMRVI1 
(Vanderperre et al., 
2013) 
134 The sPEP colocalizes to the nucleus and interacts with BRCA1  
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Table A4. Parameters set for MASCOT MS/MS ion search. 
 
	    
Fixed modification  
•  Carbamidomethyl 
(C)  
Variable 
modifications  
•  Gly->pyro-
Glu ( N-term 
Q) 
•  Gln->pyro-
Glu ( N-term 
Q) 
•  Oxidation (M)  
Missed cleavages  
•  Allow up to 2 
Peptide 
tolerance (±)  
•  50 ppm  
Peptide charge 
•  2+, 3+, & 4+ 
Taxonomy  
•  Homo sapiens  
Enzyme 
digestion  
•  Semi-trypsin  
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Appendix 2 
Details of protocols in 2D Quant kit 
Peptide samples were quantified using 2D Quant kit according to the manufacturer’s specifications. 
2 mg/ml Bovine serum albumin (BSA) standard solution provided with the kit was used to prepare 
a standard curve (0 µl, 2.5 µl, 5 µl, 7.5 µl, 10 µl and 12.5 µl). 2 µl and 15 µl of each protein sample 
were analysed each time. Precipitant (250 µl) was added to each tube and vortexed briefly. Tubes 
were then incubated for 2 to 3 minutes at room temperature. Co-precipitant (250 µl) was added to 
each tube followed by vortexing and centrifugation at 10, 000 x g for 5 minutes. Supernatant was 
then decanted and removed with pipette carefully. 50 µl copper solution and 200 µl of water were 
added into each tube and vortexed briefly. 500 µl working colour reagent was added into each tube. 
Tubes were then incubated for 20 minutes at room temperature before reading the absorbance, 
standard at 480nm using water as reference. 
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Appendix 3 
Characterisation of sPEPs found in HEK cells 
Conservation of sPEPs with other species 
a) sPEP translated from LINC00950 non-coding RNA 
Blast result using nucleotide sequence- Blastn result: 
Description Total score Query cover E value Identity 
Human DNA sequence from clone RP11-112J3 on 
chromosome 9p13.1-13.3, complete sequence 
942 100% 0.0 100% 
Homo sapiens clone 23583 mRNA sequence 941 99% 0.0 100% 
Homo sapiens mRNA; cDNA DKFZp547N0218 
(from clone DKFZp547N0218) 
935 100% 0.0 99% 
PREDICTED: Cavia porcellus olfactory receptor 
13C3-like (LOC100729728), mRNA 
113 20% 1e-21 86% 
Blast search using protein sequence- Blastp result: 
Conserved Species Identities/ E-value 
Homo sapiens cartilage-hair hypoplasia region gene 
sequence 
100% / 1e-08 
Query  1      LRISNGSDEISLPLTYWPWPKCL*  72 
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              LRISNGSDEISLPLTYWPWPKCL* 
Sbjct  72937  LRISNGSDEISLPLTYWPWPKCL*  73008  
PREDICTED: nesprin-1-like [Neolamprologus brichardi] 73 % / 106 
Query  1     ISNGSDEISLP  11 
             IS  GSDEI  P 
Sbjct  2877   ISAGSDEIAFP  2887 
PREDICTED: aldehyde dehydrogenase family 9 member 
A1-B-like [Maylandia zebra] 
73 % / 191 
Query  1   ISNGSDEISLP  11 
           IS GS  EI LP 
Sbjct  25  ISSGSVEITLP  35 
coiled-coil domain-containing protein [Cricetulus griseus] 73% / 263 
Query  1    ISNGSDEISLP  11 
            IS  SD+ISLP 
Sbjct  1322  IS--SDDISLP  1330 
Fat4 protein, partial [Mus musculus] 80 % / 78 
Query  2    SNGSDEISLP  11 
            S  G DEISLP 
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Sbjct  1531  SQGPDEISLP  1540 
protocadherin Fat 4 [Rattus norvegicus] 80 %/ 78 
Query  2     SNGSDEISLP  11 
             S  G DEISLP 
Sbjct  4491   SQGPDEISLP  4500 
Fat4 [Mus musculus] 80 % / 78 
Query  2     SNGSDEISLP  11 
             S  G DEISLP 
Sbjct  4493   SQGPDEISLP  4502 
hypothetical protein PANDA_000833 [Ailuropoda 
melanoleuca] 
69 % / 105 
Query  1  ISNGSDEI--SLP  11 
          ISNGS  E+ SLP 
Sbjct  809 ISNGSAEVDLSLP  821 
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b) sPEP translated from TM9SF3 
Blast result using nucleotide sequence- Blastn result: 
Description Total score Query cover E value Identity 
PREDICTED: Pongo abelii transmembrane 9 superfamily 
member 3 (TM9SF3), mRNA 
449 100% 6e-123 93% 
PREDICTED: Macaca fascicularis uncharacterized 
LOC101926339 (LOC101926339), mRNA 
363 100% 8e-97 88% 
PREDICTED: Macaca mulatta transmembrane 9 superfamily 
member 3, transcript variant 3 (TM9SF3), mRNA 
363 100% 8e-97 88% 
PREDICTED: Orcinus orca transmembrane 9 superfamily 
member 3 (TM9SF3), mRNA 
337 98% 5e-89 87% 
PREDICTED: Odobenus rosmarus divergens transmembrane 9 
superfamily member 3 (TM9SF3), mRNA 
311 89% 3e-81 87% 
Bos taurus transmembrane 9 superfamily member 3 (TM9SF3), 
mRNA 
272 91% 1e-69 85% 
PREDICTED: Canis lupus familiaris transmembrane 9 
superfamily member 3 (TM9SF3), transcript variant X1, mRNA 
254 82% 5e-64 85% 
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Blast search using protein sequence- Blastp result: 
Conserved Species Identities/ E-value 
PREDICTED: fibroblast growth factor 3 [Bos mutus] 81 % / 0.22 
Query  1   ATAAAEEAAAGPGPVR  16 
           A AAAEEA  AGPGP R 
Sbjct  246  AAAAAEEA-AGPGPGR  260 
PREDICTED: epiplakin, partial [Condylura cristata] 80 % / 0.32 
Query  2    TAAAEEAAAGPGPVR  16 
            TA   EEAAAGPG VR 
Sbjct  1021  TAIVEEAAAGPGRVR  1035 
PREDICTED: cryptochrome-2 [Erinaceus europaeus] 86 % / 0.42 
Query  2   TAAAEEAAAGPGPV  15 
           TAAA  AAAGPGPV 
Sbjct  7    TAAATAAAAGPGPV  20 
PREDICTED: LOW QUALITY PROTEIN: ubiquitin 
specific peptidase 35 [Bos mutus] 
86 % / 0.59 
Query  3    AAA--EEAAAGPGP  14 
            AAA  EEAAAGPGP 
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Sbjct  744  AAADGEEAAAGPGP  757 
PREDICTED: ubiquitin carboxyl-terminal hydrolase 35 
[Bubalus bubalis] 
86 % 0.59 
Query  3   AAA--EEAAAGPGP  14 
           AAA  EEAAAGPGP 
Sbjct  728  AAADGEEAAAGPGP  741 
PREDICTED: ubiquitin carboxyl-terminal hydrolase 35 
[Bos taurus] 
86 % / 0.58 
Query  3    AAA--EEAAAGPGP  14 
            AAA  EEAAAGPGP 
Sbjct  735  AAADGEEAAAGPGP  748 
zinc finger protein ZIC 5 [Mus musculus] 79 % / 2.0 
Query  1   ATAAAEEAAAGPGP  14 
           AAAA    AAAGPGP 
Sbjct  310  AAAAAAAAAAGPGP  323 
PREDICTED: MAP kinase-interacting 
serine/threonine-protein kinase 2 [Cavia porcellus] 
91 % / 3.6 
Query  4   AAEEAAAGPGP  14 
           AAEEAAAG GP 
Sbjct  413  AAEEAAAGQGP  423 
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PREDICTED: ubiquitin-associated domain-containing 
protein 1 [Macaca fascicularis] 
85 % / 5.0 
Query  1   ATAAAEEAAAGPG  13 
           ATAAA  EAAAG G 
Sbjct  308  ATAAAPEAAAGAG  320 
zinc family member 5 protein [Homo sapiens] 83 % / 9.3 
Query  3   AAAEEAAAGPGP  14 
           AAA  AAAGPGP 
Sbjct  314  AAAAAAAAGPGP  325 
paralemin [Homo sapiens] 69 % / 12 
Query  1    ATAAAEEAAAGPGPVR  16 
              AAAAE  AAP  PVR 
Sbjct  104  APAAAKENAAAPSPVR  119 
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c) sPEP translated from PTPN21 
Blast result using nucleotide sequence- Blastn result: 
Description Total score Query cover E value Identity 
PREDICTED: Homo sapiens spermatogenesis associated 7 
(SPATA7), transcript variant X7, mRNA 
244 100% 5e-62 100% 
PREDICTED: Nomascus leucogenys protein tyrosine 
phosphatase, non-receptor type 21 (PTPN21), mRNA 
243 100% 2e-61 100% 
PREDICTED: Gorilla gorilla gorilla tyrosine-protein phosphatase 
non-receptor type 21-like (LOC101141605), mRNA 
243 100% 2e-61 100% 
PREDICTED: Pan troglodytes protein tyrosine phosphatase, 
non-receptor type 21, transcript variant 1 (PTPN21), mRNA 
243 100% 2e-61 100% 
Blast search using protein sequence- Blastp result: 
Conserved Species  Identities/ E-value 
PREDICTED: protein FAM13A-like [Condylura cristata] 78 % / 83 
Query  1    GTITEYLSR  9 
            GTI  EYL R 
Sbjct  93    GTIVEYLTR  101 
similar to F-box protein FBL2, isoform CRA_b [Rattus 75 % / 273 
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norvegicus] Query  2    TITEYLS  R  9 
            TITEY+   R 
Sbjct  109   TITEYMGR  116 
apolipoprotein B editing complex 1, isoform CRA_b [Mus 
musculus] 
86 % / 388 
Query  3   ITEYLSR  9 
           ITE+LSR 
Sbjct  111  ITEFLSR  117 
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Appendix 4 
a) Characterisation of sPEP translated from LINC00950 non-coding RNA found in HEK cells 
Information was obtained using a web-based peptide/protein analysis tool from LifeTein 
(http://lifetein.com/peptide-analysis-tool.html), indicating properties of the sPEP including protein 
hydrophobicity, secondary structure prediction, transmembrane region predictions, protein 
flexibility. 
Primary information of sPEP translated from LINC00950 non-coding RNA 
Interpreted amino acid sequence YYYHPVPIPVPQQIFWLLNVLNDFLRISNGSDEISLPLTYWPWPKCL 
Number of Standard Residues 47 
Chemical Formula C!"#H!"#N!"O!"S 
Molecular Weight 5647.86 g/mol 
Sequence Composition (in 
percentage) 
Acidic: 6.38 
Basic: 6.38 
Neutral: 36.17 
Hydrophobic: 51.06 
Amino Acid Composition C = 1 ( 2.13)  D = 2 ( 4.26)  E = 1 ( 2.13)  F = 2 ( 4.26)  
G = 1 ( 2.13)  H = 1 ( 2.13)  I = 4 ( 8.51)  K = 1 ( 2.13)   
L = 7 (14.89)  N = 3 ( 6.38)  P = 7 (14.89)  Q = 2 ( 4.26)   
R = 1 ( 2.13)  S = 3 ( 6.38)  T = 1 ( 2.13)  V = 3 ( 6.38)   
W = 3 ( 6.38)  Y = 4 ( 8.51) 
Isoelectric Point (pI) 5.29 
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Net Charge at pH 7 -0.98 
Charge 0 
Charge Attribute Neutral 
Secondary Structure Predicition 
Amphiphilicity Helix Y Y Y H P V P I P V P Q Q I F W L L N V L N D F L R I S N G S D E I S L P L T Y 
W P W P K C L 
Legend: Helix 
Chou-Fasman 
Prediction 
Y Y Y H P V P I P V P Q Q I F W L L N V L N D F L R I S N G S D E I S L P L T 
Y W PW P K C L 
Legend:Alpha,Beta, Turn 
GOR-I Prediction Y Y Y H P V P 
I P V P Q Q I F W L L N V L N D F L R I S N G S D E I S L P L T Y W P W P K C 
L 
Legend:Alpha,Beta, Turn, Coil 
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b) Characterisation of sPEP translated from TM9SF3 found in HEK cells 
Information wasobtained using a web-based peptide/protein analysis tool from LifeTein 
(http://lifetein.com/peptide-analysis-tool.html), indicating properties of the sPEP including protein 
hydrophobicity, secondary structure prediction, transmembrane region predictions, protein 
flexibility. 
Primary information of sPEP translated from TM9SF3 
Interpreted amino acid sequence EEEAEEARGAGEAQERAVTATAAAEEAAAGPGPVRL
SAPRGCESAAAEAAAAEEAAAGGGVGEPAPGRRGAE
DEAAAWRSWRGGGRRAVAAAAAAAPDPGGRARTH
VSR 
Number of Standard Residues 109 
Chemical Formula C!"#H!""N!"#O!"#S 
Molecular Weight 10568.73 g/mol 
Sequence Composition (in 
percentage) 
Acidic: 16.51 
Basic: 12.84 
Neutral: 28.44 
Hydrophobic: 42.2 
Amino Acid Composition A = 37 (33.94)  C = 1 ( 0.92)  D = 2 ( 1.83)  E = 16 (14.68) 
G = 16 (14.68)  H = 1 ( 0.92)  L = 1 ( 0.92)  P = 7 
( 6.42)  Q = 1 ( 0.92)  R = 13 (11.93)  S = 4 ( 3.67)  T = 3 
( 2.75)V = 5 ( 4.59)  W = 2 ( 1.83) 
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Isoelectric Point (pI) 4.71 
Net Charge at pH 7 -4.96 
Charge -4 
Charge Attribute Acidic 
Antigenicity, Hydrophobicity & Hydrophilicity 
Secondary Structure Predicition 
Amphiphilicity 
Helix 
E E E A E E A R G A G E A Q E R A V T A T A A A E E A A A G P G P V R L 
S A P R G C E S A A A E A A A A E E A A A G G G V G E P A P G R R G A E D E A 
A A W R SW R G G G R R A V A A A A A A A P D P G G R A R T H V S R 
Legend: Helix 
Chou-Fasman 
Prediction 
E E E A E E A R G A G E A Q E R A V T A T A A A E E A A A G P G P V R L 
S A P R G C E S A A A E A A A A E E A A A G G G V G E P A P G R R G A E D E A 
A A W R S WR G G G R R A V A A A A A A A P D P G G R A R T H V S R 
Legend:Alpha,Beta, Turn 
GOR-I Prediction E E E A E E A 
R G A G E A Q E R A V T A T A A A E E A A A G P G P V R L S A P RG C E S A 
A A E A A A A E E A A A G G G V G E P A P G R R G A E D E A A A W RS W R 
G G G R R A V A A A A A A A P D P G G R A R T H V S R 
Legend:Alpha,Beta, Turn, Coil 
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c) Characterisation of sPEP translated from PTPN21 found in HEK cells 
Information was obtained using a web-based peptide/protein analysis tool from LifeTein 
(http://lifetein.com/peptide-analysis-tool.html), indicating properties of the sPEP including protein 
hydrophobicity, secondary structure prediction, transmembrane region predictions, protein 
flexibility. 
Primary information of sPEP translated from PTPN21 
Interpreted amino acid sequence MGLYCHTGTITEYLSRFLADGMGTGNCNYSNGDSRR
GGWKGEEL 
Number of Standard Residues 44 
Chemical Formula C!"#H!"#N!"O!"S! 
Molecular Weight 4819.55 g/mol 
Sequence Composition (in 
percentage) 
Acidic: 11.36 
Basic: 11.36 
Neutral: 43.18 
Hydrophobic: 34.09 
Amino Acid Composition A = 1 ( 2.27)  C = 2 ( 4.55)  D = 2 ( 4.55)  E = 3 ( 6.82)   
F = 1 ( 2.27)  G = 9 (20.45)  H = 1 ( 2.27)  I = 1 ( 2.27)   
K = 1 ( 2.27)  L = 4 ( 9.09)  M = 2 ( 4.55)  N = 3 ( 6.82)   
R = 3 ( 6.82)  S = 3 ( 6.82)  T = 4 ( 9.09)  W = 1 ( 2.27)   
Y = 3 ( 6.82) 
Isoelectric Point (pI) 5.48 
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Net Charge at pH 7 -1.07 
Charge 0 
Charge Attribute Neutral 
Secondary Structure Predicition 
Amphiphilicity 
Helix 
M G L Y C H T G T I T E Y L S R F L A D G M G T G N C N Y S N G D S R R G G W 
K G E E L 
Legend: Helix 
Chou-Fasman 
Prediction 
M G L Y C H T G T I T E Y L S R F L A D G M G T G N C N Y S N G D S R R G 
G W KG E E L 
Legend:Alpha, Turn 
GOR-I Prediction M G L Y C H T G T I T E Y L S R F L A D G M G T G N C N Y S N G D S R R G G 
W K G E E L 
Legend:Alpha,Beta, Turn, Coil 
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Appendix 5 
a) Protein secondary structure prediction of the sPEPs found in HEK cells 
Protein secondary structure prediction of sPEP translated from LINC00950 non-coding RNA found 
in HEK cells 
Information was analysed using Protein structure prediction on the web: a case study using the 
Phyre server (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index). 
Protein structure prediction- sPEP translated from LINC00950 non-coding RNA 
 
 
Confidence: 31.3%  Coverage: 11% 
5 residues (11% of the sequence) have been modelled with 31.3% confidence by the single 
highest scoring template. 
Molecular description 
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Classification Apoptosis 
Structure Weight 3321.95 
Molecule Activator of apoptosis harakiri (Harakiri is a BH3-only member of 
the Bcl-2 family that localizes in membranes and induces cell death by bindin
g toprosurvival Bcl-x(L) and Bcl-2.) 
Polymer 1 
Length 32 
Chain  A 
 
  
127	  
	  
b) Protein secondary structure prediction of sPEP translated from TM9SF3 found in HEK cells 
Information was analysed using Protein structure prediction on the web: a case study using the 
Phyre server (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index). 
Protein structure prediction- sPEP translated from TM9SF3 
 
 
Confidence: 5.1%  Coverage: 6% 
6 residues (6% of the sequence) have been modelled with 5.1% confidence by the single highest 
scoring template. 
PDB Molecule putative uncharacterized protein 
Chain  A 
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c) Protein secondary structure prediction of sPEP translated from PTPN21 found in HEK cells 
Information was analysed using Protein structure prediction on the web: a case study using the 
Phyre server (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index). 
Protein structure prediction- sPEP translated fromPTPN21 
 
Confidence: 27.6%  Coverage: 50% 
22 residues (50% of the sequence) have been modelled with 27.6% confidence by the single 
highest scoring template. 
Fold: 6-bladed beta-propeller 
Superfamily: Sialidases 
Family: Sialidases (neuraminidases) 
Molecular description 
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PDB Description structures of aromatic inhibitors of influenza virus neuraminidase 
PDB 
Compounds 
influenza a subtype n2 neuraminidase 
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Appendix 6 
Protein localisaion prediction of the sPEPs found in HEK cells 
a) Subcellular Localization Prediction for the sPEP translated from LINC00950 non-coding RNA 
found in HEK cells 
Information was analysed using Protein structure prediction on the web: The PredictProtein 
server Rost, LocTree2 (https://www.predictprotein.org/), predicting the subcellular localisation of 
all domains. 
Protein Localisation Prediction- sPEP translated fromLINC00950 non-coding RNA 
Eukarya domain Secreted 
Prediction confidence 51 
b) Subcellular Localization Prediction for the sPEP translated from TM9SF3 found in HEK cells 
Information was analysed using Protein structure prediction on the web: The PredictProtein 
server Rost, LocTree2 (https://www.predictprotein.org/), predicting the subcellular localisation of 
all domains. 
Protein Localisation Prediction- sPEP translated fromTM9SF3 
Eukarya domain Cytoplasm 
Prediction confidence 46 
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c) Subcellular Localization Prediction for the sPEP translated from PTPN21 found in HEK cells 
Information was analysed using Protein structure prediction on the web: The PredictProtein 
server Rost, LocTree2 (https://www.predictprotein.org/), predicting the subcellular localisation of 
all domains. 
Protein Localisation Prediction- sPEP translated fromPTPN21 
Eukarya domain Secreted 
Prediction confidence 44 
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Appendix 7 
Gene and protein expression in a range of cell/tissue types of the sPEPs found in HEK cells 
a) Gene and protein expression in a range of cell/tissue types of LINC00950 non-coding RNA 
associated with the identified sPEP 
Information were analysed using a web-based gene and protein function analysis tool from BioGPF 
(http://biogps.org). X-axis represents the expression level in relative units in different cell/tissue 
types shown in bars. Higher value indicates higher expression and gene activity. The highest 
expression is in the superior cervical ganglion (shown in light yellow bar). 
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b) Gene and protein expression in a range of cell/tissue types of TM9SF3 human mRNA associated 
with the identified sPEP 
Information were analysed using a web-based gene and protein function analysis tool from BioGPF 
(http://biogps.org). X-axis represents the expression level in relative units in different cell/tissue 
types shown in bars. Higher value indicates higher expression and gene activity. The highest 
expression is in the colon (shown in blue green bar). 
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c) Gene and protein expression in a range of cell/tissue types of PTPN21 human mRNA 
associated with the identified sPEP 
Information were analysed using a web-based gene and protein function analysis tool from BioGPF 
(http://biogps.org). X-axis represents the expression level in relative units in different cell/tissue 
types shown in bars. Higher value indicates higher expression and gene activity. The higher 
expressions are in the cardiac myocytes (shown in dark blue bar), lymphoma (shown in light blue 
bar), and liver (shown in light brown bar). 
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Appendix 8 
Motif prediction for the sPEPs found in HEK cells 
a) Motif prediction for the sPEP translated from LINC00950 non-coding RNA found in HEK cells 
Information was analysed using MyHit, a free database website devoted to protein domains: 
http://myhits.isb-sib.ch/cgi-bin/motif_scan. 
Motif Prediction Results- sPEP translated fromLINC00950 non-coding RNA 
Database of motifs Match score Motif informationc 
PROSITE patterns 
(frequent match 
producers) [freq_pat] 
Status: Questionable or weak match: 
determining the true or false negative 
status of this match requires additional 
biological evidences 
Position: 29-32 
ASN_GLYCOSYLATION 
N-glycosylation site 
b) Motif prediction for the sPEP translated from TM9SF3 found in HEK cells 
Information was analysed using MyHit, a free database website devoted to protein domains: 
http://myhits.isb-sib.ch/cgi-bin/motif_scan. 
Motif Prediction Results- sPEP translated fromTM9SF3 
Database of motifs Match score Motif informationc 
PROSITE profiles Status: A strong match: it is very 
unlikely that this match is a false 
ALA_RICH 
Alanine-rich region profile 
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positive 
Position: 9-46 
raw-score = 87 
N-score = 16.143 
E-value = 1.5e-09 
PROSITE patterns 
(frequent match 
producers) [freq_pat] 
Status: Questionable or weak match: 
determining the true or false negative 
status of this match requires additional 
biological evidences 
Position: 66-69; 84-87 
AMIDATION 
Amidation site 
PROSITE patterns 
(frequent match 
producers) [freq_pat] 
Status: Questionable or weak match: 
determining the true or false negative 
status of this match requires additional 
biological evidences 
Position: 9-14; 41-46; 58-63; 84-89 
MYRISTYL 
N-myristoylation site 
PROSITE patterns 
(frequent match 
producers) [freq_pat] 
Status: Questionable or weak match: 
determining the true or false negative 
status of this match requires additional 
biological evidences 
Position: 80-82 
PKC_PHOSPHO_SITE 
Protein kinase C phosphorylation 
site 
137	  
	  
Pfam HMMs (local 
models) [pfam_fs] 
Status: Questionable or weak match: 
determining the true or false negative 
status of this match requires additional 
biological evidences 
Position:67-78 
raw-score = 2.1 
N-score = 8.285 
E-value = 0.11 
Gastrin 
Gastrin/cholecystokinin family 
c) Motif prediction for the sPEP translated from PTPN21 found in HEK cells 
Information was analysed using MyHit, a free database website devoted to protein domains: 
http://myhits.isb-sib.ch/cgi-bin/motif_scan. 
Motif Prediction Results- sPEP translated fromPTPN21 
Database of motifs Match score Motif informationc 
PROSITE patterns 
(frequent match 
producers) [freq_pat] 
Status: Questionable or weak match: 
determining the true or false negative 
status of this match requires additional 
biological evidences 
Position: 28-31 
ASN_GLYCOSYLATION 
N-glycosylation site 
PROSITE patterns 
(frequent match 
Status: Questionable or weak match: 
determining the true or false negative 
CK2_PHOSPHO_SITE 
Casein kinase II phosphorylation 
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producers) [freq_pat] status of this match requires additional 
biological evidences 
Position: 9-12; 30-33 
site 
PROSITE patterns 
(frequent match 
producers) [freq_pat] 
Status: Questionable or weak match: 
determining the true or false negative 
status of this match requires additional 
biological evidences 
Position: 21-26; 37-42 
MYRISTYL 
N-myristoylation site 
PROSITE patterns 
(frequent match 
producers) [freq_pat] 
Status: Questionable or weak match: 
determining the true or false negative 
status of this match requires additional 
biological evidences 
Position:34-36 
PKC_PHOSPHO_SITE 
Protein kinase C phosphorylation 
site. 
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Appendix 9 
Analysis of CGG-repeat uORFs in neural transcripts using uPEPperoni 
To explore traces of conservation between human CGG-repeat uORFs in neural transcripts with 
different species, uORFs (a neural uORF list from John Carson’s search group) containing 
CGG-repeat elements were analysed using uPEPperoni online search engine, which detects 
conserved uORFs in eukaryotic transcripts. 23 hits of conserved uPEPs in other species were 
obtained in total 226 human neural uORFs from the list. 
Gene symbol Gene name CGG repeats 
Location of 
CGG repeats 
Chromosomal location 
of the CGG repeats 
Conserved species 
DEDD 
Death effector domain 
containing 
cgg 5' 
Chr1: 
159369054-159369074 
Human, mouse, bos 
taurus, pongo abeli, 
macaca mulatt 
B4GALT2 
Betaglcnac beta 1,4- 
galactosyltransferase, 
polypeptide 2 
cgg 5' 
Chr1: 
44217597-44217623 
Human, mouse, bos 
taurus 
RXRG 
Retinoid x receptor, 
gamma 
cgg 5' 
Chr1: 
163681015-163681035 
Human, mouse, rat, 
bos taurus, pongo 
abeli, macaca mulatt 
NRXN1 Neurexin 1 cgg 5' 
Chr2: 
50427515-50427541 
Human, bos taurus,  
TXNDC5 
Thioredoxin domain 
containing 5 
cgg ORF 
Chr6: 
7855870-7855887 
Human, danio rerio 
HDGFL1 
Hepatoma derived growth 
factor-like 1 
cgg ORF 
Chr6: 
22678328-22678345 
Human, bos taurus,  
PDGFA 
Platelet-derived growth 
factor alpha polypeptide 
cgg 5' 
Chr7: 
525595-525612 
Human, mouse, canis 
rupus 
ZNF212 Zinc finger protein 212 cgg Promotor/ 5’ 
Chr7: 
148567696-148567713 
Human, ciona 
intestinalis 
SLCO5A1 
Solute carrier organic 
anion transporter family, 
member 5a1 
cgg 5' 
Chr8: 
70907784-70907807 
Human, mouse, rat 
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NTNG2 Netrin g2 cgg 5' 
Chr9: 
134027273-134027290 
Human, rat, bos 
taurus, macaca mulatt 
KCNMA1 
Potassium large 
conductance 
calcium-activated channel, 
subfamily m, alpha 
member 1 
cgg ORF 
Chr10: 
79067351-79067371 
Human, bos taurus,  
FAM155A 
family with sequence 
similarity 155, member A 
homolog 1 (drosophila) 
cgg ORF 
Chr13: 
107316518-107316535 
Human, pongo abeli 
ARHGEF7 
Rho guanine nucleotide 
exchange factor (gef) 7 
cgg 5' 
Chr13: 
110565785-110565802 
Human, mouse, rat 
PABPN1 
Poly(a) binding protein, 
nuclear 1 
cgg 5' 
Chr14: 
22860523-22860540 
Human, bos taurus,  
ARIH1 
Ariadne 
ubiquitin-conjugating 
enzyme E2 binding protein 
homolog 1  
cgg ORF 
Chr15: 
70554271-70554291 
Human, gallus gallus 
SMG1 
SMG1 
phosphatidylinositol 
3-kinase-related kinase 
cgg ORF 
Chr16: 
18844812-18844829 
Human, xenopus 
laevis 
ST3GAL2 
ST3 beta-galactoside 
alpha-2,3-sialyltransferase 
2 
cgg 5' 
Chr16: 
69030429-69030452 
Human, mouse, bos 
taurus, macaca mulatt 
ZFHX3 Zinc finger homeobox 3 cgg ORF 
Chr16: 
71379096-71379116 
Human, mouse 
ZBTB4 
Zinc finger and btb domain 
containing 4 
cgg 5' 
Chr17: 
7323646-7323663 
Human, mouse 
WIPF2 
WAS/WASL interacting 
protein family, member 2 
cgg 5' 
Chr17: 
35629149-35629175 
Human, sus scrofa 
TCF4 Transcription factor 4 cgg 5' 
Chr18: 
51406386-51406406 
Human, mouse 
CAPNS1 Calpain, small subunit 1 cgg ORF 
Chr19: 
41323783-41323800 
Human, oryctolagus 
cuniculus 
DSCAM 
Down syndrome cell 
adhesion molecule 
cgg 5' 
Chr21: 
41140576-41140593 
Human, xenopus 
laevis 
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